BindingDB logo
myBDB logout

Search by Patent Identification

Patent: (prefix with "US" like US6078908)
PatentDataPatent TitleOrganizationDepositionDownloads
US9549932 488 2-(morpholin-4-yl)-1,7-naphthyridines Bayer Pharma Aktiengesellschaft 11/29/182D 3D TSV
US9718828 489 BTK Inhibitors MERCK SHARP & DOHME CORP.; MERCK SHARP & DOHME B.V. 11/29/182D 3D TSV
US9550771 93 Keto-imidazopyridine derivatives as RORc modulators Genentech, Inc. 11/29/182D 3D TSV
US9718822 68 Macrocyclic compounds as Trk kinase inhibitors Array BioPharma, Inc. 11/29/182D 3D TSV
US9718854 20 Selective glycosidase inhibitors and uses thereof Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. 11/29/182D 3D TSV
US9718820 90 Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulators JANSSEN PHARMACEUTICA NV 11/29/182D 3D TSV
US9550775 130 Substituted triazolopyridines and methods of use thereof GENENTECH, INC.; XENON PHARMACEUTICALS INC. 11/29/182D 3D TSV
US9718814 375 Cyclopropanamine compound and use thereof Takeda Pharmaceutical Company Limited 11/28/182D 3D TSV
US9718819 182 Non-nucleoside reverse transcriptase inhibitors Merck Sharp & Dohme Corp. 11/28/182D 3D TSV
US9718812 213 Substituted thiazole or oxazole P2X7 receptor antagonists Axxam S.P.A. 11/28/182D 3D TSV
US9718809 87 Bisarylsulfonamides useful in the treatment of inflammation and cancer Kancera AB 11/27/182D 3D TSV
US9718800 115 Chromenone derivatives ASTRAZENECA AB 11/27/182D 3D TSV
US9718808 144 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 11/27/182D 3D TSV
US9718793 138 Isoxazole compounds as inhibitors of heat shock proteins Vernalis (R&D) Ltd.; Cancer Research Technology Limited; The Institute of Cancer Research 11/27/182D 3D TSV
US9718792 101 Isoxazoline hydroxamic acid derivatives as LpxC inhibitors Novartis AG 11/27/182D 3D TSV
US9718790 2250 Triazine derivative and pharmaceutical composition having an analgesic activity comprising the same SHIONOGI & CO., LTD. 11/27/182D 3D TSV
US9718803 375 Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors Amgen Inc. 11/27/182D 3D TSV
US9718771 48 Aniline derivative, pharmaceutical composition containing same, and use thereof KISSEI PHARMACEUTICAL CO., LTD. 11/16/182D 3D TSV
US9718787 9 Poly (ADP-ribose) polymerase inhibitor CHENGDU DIAO PHARMACEUTICAL GROUP CO., LTD. 11/16/182D 3D TSV
US9718780 6 Substituted pyridines as sodium channel blockers TBA 11/16/182D 3D TSV
US9714242 13 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists Bayer Intellectual Property GmbH 11/15/182D 3D TSV
US9714234 70 Carbazole carboxamide compounds Bristol-Myers Squibb Company 11/15/182D 3D TSV
US9713651 56 Compositions, methods, and systems for the synthesis and use of imaging agents Lantheus Medical Imaging, Inc. 11/15/182D 3D TSV
US9714236 207 Compounds and methods for inhibiting JAK ASTRAZENECA AB 11/15/182D 3D TSV
US9713612 30 Compounds for treatment of cancer CUREGENIX, INC. 11/15/182D 3D TSV
US9714252 7 Cyclic sulfonamides as sodium channel blockers Purdue Pharma L.P. 11/15/182D 3D TSV
US9714241 375 Cyclopropanamine compound and use thereof Takeda Pharmaceutical Company Limited 11/15/182D 3D TSV
US9714266 46 Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (AKR1C3) BAYER PHARMA AKTIENGESELLSCHAFT 11/15/182D 3D TSV
US9714224 8 Heterocyclic compounds and methods of their use NOVARTIS AG 11/15/182D 3D TSV
US9714230 511 Histone demethylase inhibitors Celgene Quantical Research, Inc. 11/15/182D 3D TSV
US9713606 584 Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C Boehringer Ingelheim International GmbH 11/15/182D 3D TSV
US9714247 452 Multiple kinase pathway inhibitors Tolero Pharmaceuticals, Inc.; Mannkind Corporation 11/15/182D 3D TSV
US9717745 5 Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases ZHEJIANG DTRM BIOPHARMA CO. LTD. 11/15/182D 3D TSV
US9718760 257 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN; EASTERN MICHIGAN UNIVERSITY 11/15/182D 3D TSV
US9714249 134 Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease Novartis AG 11/15/182D 3D TSV
US9714235 40 Quinazoline derivatives, compositions thereof, and use as pharmaceuticals Shanghai Fochon Pharmaceutical Co., Ltd. 11/15/182D 3D TSV
US9717714 14 Spirocyclic CETP inhibitors Merck Sharp & Dohme Corp. 11/15/182D 3D TSV
US9714221 654 Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof SANOFI 11/15/182D 3D TSV
US9714232 72 Substituted piperazine compounds and methods of use thereof SUNSHINE LAKE PHARMA CO., LTD. 11/15/182D 3D TSV
US9714244 46 Substituted pyrido[4,3-d]pyrimidines as Wee-1 inhibitors ALMAC DISCOVERY LIMITED 11/15/182D 3D TSV
US9556130 73 4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139 Takeda Pharmaceutical Company Limited 11/08/182D 3D TSV
US9550741 612 Benzoisothiazole compounds and methods of treating schizophrenia Shanghai Institute of Pharmaceutical Industry 11/08/182D 3D TSV
US9556150 59 Inhibitors of bruton's tyrosine kinase Hoffmann-La Roche Inc.; Chugai Pharmaceutical Co. 11/08/182D 3D TSV
US9708370 88 Azapeptides as CD36 binding compounds VALORISATION-RECHERCHE, LIMITED PARTNERSHIP; VALORISATION HSJ, LIMITED PARTNERSHIP 11/07/182D 3D TSV
US9546162 91 Compounds and methods for skin repair ALLERGAN, INC. 11/07/182D 3D TSV
US9533987 230 Heterocyclic derivates Kalvista Pharmaceuticals Limited 11/07/182D 3D TSV
US9546164 648 Substituted benzamides and methods of use thereof GENENTECH, INC.; XENON PHARMACEUTICALS INC. 11/07/182D 3D TSV
US9708337 36 Aryl amide-based kinase inhibitors Bristol-Myers Squibb Company 11/05/182D 3D TSV
US9708336 2511 Metallo-beta-lactamase inhibitors Merck Sharp & Dohme Corp. 11/05/182D 3D TSV
US9708359 143 Pyrrolopyrimidine nucleosides and analogs thereof Chimerix, Inc.; The Regents of the University of Michigan 11/05/182D 3D TSV
US9708340 96 Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors Hoffmann-La Roche Inc. 11/05/182D 3D TSV
US9708333 86 Fused bicyclic 1,2,4-triazine compounds as TAM inhibitors Incyte Corporation 11/01/182D 3D TSV
US9708309 24 Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use ORYZON GENOMICS, S.A. 10/31/182D 3D TSV
US9708311 143 Benzimidazole derivatives as EP4 antagonists BAYER PHARMA AKTIENGESELLSCHAFT 10/31/182D 3D TSV
US9708318 856 Bicyclic heterocycles as FGFR4 inhibitors Incyte Corporation 10/31/182D 3D TSV
US9708302 46 Flouro-naphthyl derivatives HOFFMANN-LA-ROCHE INC. 10/31/182D 3D TSV
US9708313 142 Substituted pyrido[3,4-b]pyrazines as GPR6 modulators Takeda Pharmaceutical Company Limited 10/31/182D 3D TSV
US9708325 62 Sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection Hoffmann-La Roche Inc. 10/31/182D 3D TSV
US9708279 100 2-acylaminothiazoles for the treatment of cancer UNIVERSITÁ DEGLI STUDI DI MILANO—BICOCCA; UNIVERSITÈ DE GENÈVE; UNIVERSITÈ CLAUDE BERNARD LYON 1 10/30/182D 3D TSV
US10053471 17 Azabenzimidazole derivatives Boehringer Ingelheim International GmbH 10/30/182D 3D TSV
US9708266 40 Cyclohexyl pyridine derivative KISSEI PHARMACEUTICAL CO., LTD. 10/30/182D 3D TSV
US9708253 135 Cyclohexyl sulfone RORγ modulators Bristol-Myers Squibb Company 10/30/182D 3D TSV
US9701672 77 Dihydropyridinone MGAT2 inhibitors for use in the treatment of metabolic disorders Bristol-Myers Squibb Company 10/30/182D 3D TSV
US9708275 12 Heterocyclic compounds and methods for their use NOVARTIS AG 10/30/182D 3D TSV
US9707233 368 Heterocyclylamines as PI3K inhibitors Incyte Holdings Corporation; Incyte Corporation 10/30/182D 3D TSV
US9708272 22 Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase TES Pharma S.r.l. 10/30/182D 3D TSV
US9700563 3 Kappa opioid receptor compounds MediSynergies, LLC 10/30/182D 3D TSV
US10053462 195 P2X7 modulators Janssen Pharmaceutica NV 10/30/182D 3D TSV
US9701669 34 Preparation and use of 7a-amide substituted- 6,6-difluoro bicyclic himbacine derivatives as PAR-1 receptor antagonists Merck Sharp & Dohme Corp. 10/30/182D 3D TSV
US9708269 7 Process for making isoquinoline compounds FibroGen, Inc. 10/30/182D 3D TSV
US9701670 374 Pyrazolyl-ureas as kinase inhibitors RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED 10/30/182D 3D TSV
US10053465 286 Pyrrolopyrimidine derivatives as TAM inhibitors Incyte Corporation 10/30/182D 3D TSV
US9708268 42 ROR modulators and their uses INNOV17 LLC 10/30/182D 3D TSV
US9707205 16 S1P receptors modulators and their use thereof AKAAL PHARMA PTY LTD. 10/30/182D 3D TSV
US9701693 4 Selective glycosidase inhibitors and uses thereof Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. 10/30/182D 3D TSV
US9701685 18 Spiropyrrolidines as MDM2 inhibitors Hudson Biopharma Inc. 10/30/182D 3D TSV
US9708295 51 Substituted 2-aminopyridine protein kinase inhibitor CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.; Centaurus Biopharma Co., Ltd.; LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. 10/30/182D 3D TSV
US10053463 422 Substituted [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators Janssen Pharmaceutica NV 10/30/182D 3D TSV
US9708270 91 Substituted spiropiperidinyl compounds useful as GPR120 agonists Merck Sharp & Dohme Corp. 10/30/182D 3D TSV
US9701663 37 Sulfonamide retinoic acid receptor-related orphan receptor modulators and uses thereof INNOV17 LLC 10/30/182D 3D TSV
US9708274 328 Sulfoximine substituted quinazolines for pharmaceutical compositions EVOTEC INTERNATIONAL GMBH 10/30/182D 3D TSV
US10053461 41 Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection Hoffmann-La Roche Inc. 10/30/182D 3D TSV
US9701638 16 Therapeutic hydroxyquinolones Rutgers, The State University of New Jersey 10/30/182D 3D TSV
US9701691 25 Thienopyrimidine compounds Hoffman-La Roche Inc. 10/30/182D 3D TSV
US9550763 437 Heterocyclic ring and carbocyclic derivative SHIONOGI & CO., LTD. 10/19/182D 3D TSV
US9546173 190 Substituted pyrrolo[3,4-d]pyrimidines as kinase inhibitors Novartis AG 10/19/182D 3D TSV
US10053433 20 Androgen receptor antagonists The Regents of the University of California 10/18/182D 3D TSV
US10053454 88 Carbazole compounds useful as bromodomain inhibitors Bristol-Myers Squibb Company 10/18/182D 3D TSV
US10053456 375 Cyclopropanamine compound and use thereof Takeda Pharmaceutical Company Limited 10/18/182D 3D TSV
US10053455 22 Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors AB SCIENCE 10/18/182D 3D TSV
US10053434 24 Histone deacetylase inhibitors and compositions and methods of use thereof CHDI FOUNDATION, INC. 10/18/182D 3D TSV
US10053458 216 Pyrimidine-2,4-diamine derivative and anticancer pharmaceutical composition comprising same as effective ingredient KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY 10/18/182D 3D TSV
US10053431 514 Tetrahydro-benzodiazepinones Hoffmann-La Roche Inc. 10/18/182D 3D TSV
US9556139 260 6-substituted phenoxychroman carboxylic acid derivatives Array BioPharma Inc. 10/17/182D 3D TSV
US9556135 339 Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use Amgen, Inc. 10/17/182D 3D TSV
US10047118 7 C17-aryl substituted betulinic acid analogs ViiV HEALTHCARE UK (NO.5) LIMITED 10/17/182D 3D TSV
US10047086 158 Imidazopyridines and imidazopyrazines as LSD1 inhibitors Incyte Corporation 10/17/182D 3D TSV
US9556143 18 Metalloenzyme inhibitor compounds Viamet Pharmaceuticals, Inc. 10/17/182D 3D TSV
US9556168 60 N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof Merck Sharp & Dohme Corp. 10/17/182D 3D TSV
US9556148 86 N-cyanomethylamides as inhibitors of janus kinase Cadila Healthcare Limited 10/17/182D 3D TSV
US10052306 333 Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B CADENT THERAPEUTICS, INC. 10/17/182D 3D TSV
US9555024 35 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors University of Utah Research Foundation 10/17/182D 3D TSV
US9555022 102 Substituted triazolopyridines Bayer Intellectual Property GmbH 10/17/182D 3D TSV
US10047080 42 (R)-2-methyl-piperazine derivatives as CXCR3 receptor modulators IDORSIA PHARMACEUTICALS LTD. 10/10/182D 3D TSV
US10045974 14 2-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors H. Lundbeck A/S 10/10/182D 3D TSV
US9556175 46 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and thier use as pharmaceutical compositions Boehringer Ingelheim International GmbH 10/10/182D 3D TSV
US10047073 12 Histone deacetylase inhibitors and compositions and methods of use thereof CHDI FOUNDATION, INC 10/10/182D 3D TSV
US10047084 43 Imidazolone derivatives, pharmaceutical compositions and uses thereof BEIJING FORELANDPHARMA CO. LTD. 10/10/182D 3D TSV
US10047093 120 Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors TOLERO PHARMACEUTICALS, INC. 10/10/182D 3D TSV
US9556191 8 Aminoquinazoline derivatives and their salts and methods of use thereof SUNSHINE LAKE PHARMA CO., LTD. 10/05/182D 3D TSV
US9556160 76 Guanidine compound Astellas Pharma Inc. 10/03/182D 3D TSV
US9562012 23 PPAR-sparing compounds for the treatment of metabolic diseases Metabolic Solutions Development Company, LLC 10/03/182D 3D TSV
US9561238 6 Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy Donesta Bioscience B.V. 10/03/182D 3D TSV
US10047098 188 C5-C6-oxacyclic fused iminopyrimidinone compounds as bace inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 10/02/182D 3D TSV
US10047103 384 Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation Bristol-Myers Squibb Company; Universite de Montreal 10/02/182D 3D TSV
US10047097 105 Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds Array BioPharma Inc. 10/02/182D 3D TSV
US10047092 276 Substituted [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators Janssen Pharmaceutica NV 10/02/182D 3D TSV
US10047096 454 Substituted pyridobenzodiazepinone-derivatives and use thereof Bayer Pharma Aktiengesellschaft 10/02/182D 3D TSV
US9556181 21 Substituted pyrazolopyrimidinylamino-indazoles BAYER PHARMA AKTIENGESELLSCHAFT 09/30/182D 3D TSV
US9540377 1285 2,6,7,8 substituted purines as HDM2 inhibitors Merck Sharp & Dohme Corp. 09/26/182D 3D TSV
US9556157 6 Enhancer of zeste homolog 2 inhibitors GlaxoSmithKline Intellectual Property (No.2) Limited 09/26/182D 3D TSV
US9556170 3 Substituted-1H-benzo[d]imidazole series compounds as lysine-specific demethylase 1 (LSD1) inhibitors University of Utah Research Foundation 09/26/182D 3D TSV
US9546152 448 2-pyridyloxy-3-substituted-4-nitrile orexin receptor antagonists MERCK SHARP & DOHME CORP. 09/18/182D 3D TSV
US9546153 514 Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators Bristol-Myers Squibb Company 09/18/182D 3D TSV
US9533992 75 PDE9 inhibitors with imidazo triazinone backbone TBA 09/18/182D 3D TSV
US9550778 52 Substituted 6-aryl-imidazopyridine and 6-aryl-triazolopyridine carboxamide analogs as negative allosteric modulators of mGluR5 Vanderbilt University 09/18/182D 3D TSV
US9556111 23 Tertiary amines for use in the treatment of cardiac disorders UNIVERSITETET I OSLO 09/18/182D 3D TSV
US9556145 22 2-pyridyloxy-4-ester orexin receptor antagonists MERCK SHARP & DOHME CORP. 09/07/182D 3D TSV
US9540359 15 Dihydrooxazine or oxazepine derivatives having BACE1 inhibitory activity Shionogi & Co., Ltd. 09/07/182D 3D TSV
US9556147 7 Inhibitors of bruton's tyrosine kinase HOFFMANN-LA INC. 09/07/182D 3D TSV
US9550781 26 Kinase modulating compounds, compositions containing the same and use thereof Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 09/07/182D 3D TSV
US9556132 41 Tetrazole derivatives and their use as potassium channel modulators Saniona A/S 09/07/182D 3D TSV
US9540396 38 6-arylamino pyridone carboxamide as MEK inhibitors Centaurus Biopharma Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 08/28/182D 3D TSV
US9550755 5 Complement pathway modulators and uses thereof NOVARTIS AG 08/28/182D 3D TSV
US9546168 29 ERK inhibitors Merck Sharp & Dohme Corp. 08/28/182D 3D TSV
US9550774 2 Dihydropyrido pyrimidine compounds as autotaxin inhibitors Eli Lilly and Company 08/25/182D 3D TSV
US9527857 211 HSPC-sparing treatments for RB-positive abnormal cellular proliferation GI Therapeutics, Inc. 08/25/182D 3D TSV
US9540379 222 (1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases Boehringer Ingelheim International GmbH 08/24/182D 3D TSV
US9539260 567 Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives NOVARTIS AG 08/24/182D 3D TSV
US9540357 74 15-aryl prostaglandins as EP4 agonists, and methods of use thereof Allergan, Inc. 08/16/182D 3D TSV
US9540323 274 7-hydroxy-indolinyl antagonists of P2Y1 receptor Bristol-Myers Squibb Company 08/16/182D 3D TSV
US9540388 197 P2X7 modulators Janssen Pharmaceutica NV 08/16/182D 3D TSV
US9527851 130 Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. 08/16/182D 3D TSV
US9540352 14 Substituted 1,7-naphthyridines as dopamine D1 ligands Pfizer Inc. 08/16/182D 3D TSV
US9670229 31 5-HT3 receptor antagonists Takeda Pharmaceutical Company Limited 08/07/182D 3D TSV
US9522914 174 Azole derivative TAISHO PHARMACEUTICAL CO., LTD 08/07/182D 3D TSV
US9540364 19 Benzimidazole tetrahydrofuran derivatives Merck Sharp & Dohme Corp. 08/07/182D 3D TSV
US9676777 3 Compounds useful for producing an optically active diazabicyclooctane compound MEIJI SEIKA PHARMA CO., LTD. 08/07/182D 3D TSV
US9533999 64 Fused thiazin-3-ones as KCA3.1 inhibitors Boehringer Ingelheim International GmbH 08/07/182D 3D TSV
US9670231 368 Fused tricyclic amide compounds as multiple kinase inhibitors BeiGene, Ltd. 08/07/182D 3D TSV
US9670230 12 Heteroaryl compounds and methods of use thereof Sunovion Pharmaceuticals Inc. 08/07/182D 3D TSV
US9676783 105 Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds Array BioPharma, Inc. 08/07/182D 3D TSV
US9670255 3 Modified biotin, mutant streptavidin, and use thereof SAVID THERAPEUTICS INC. 08/07/182D 3D TSV
US9676786 4 Pharmacologically active compounds THE UNIVERSITY OF LIVERPOOL 08/07/182D 3D TSV
US9676792 4 Pyrimido-diazepinone compounds and methods of treating disorders Dana-Farber Cancer Institute, Inc. 08/07/182D 3D TSV
US9540384 58 Pyrrolidino heterocycles Hoffmann-La Roche, Inc. 08/07/182D 3D TSV
US9533995 14 Substituted N-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof Sanofi 08/07/182D 3D TSV
US9676782 342 Substituted pyrazolo[1,5-a]pyrazines as negative allosteric modulators of metabotropic glutamate receptor 3 Vanderbilt University 08/07/182D 3D TSV
US9540373 27 Substituted spirocycles Boehringer Ingelheim International GmbH 08/07/182D 3D TSV
US9676818 32 Toll-like receptor 2-agonistic lipopeptides, and method of making the same University of Kansas 08/07/182D 3D TSV
US9670211 45 Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection HOFFMANN-LA ROCHE INC. 07/07/182D 3D TSV
US9670216 58 Cannabinoid-2 agonists ALLERGAN, INC. 07/07/182D 3D TSV
US9670204 211 Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders GALAPAGOS NV 07/07/182D 3D TSV
US9670210 116 Cyclopropylamines as LSD1 inhibitors Incyte Corporation 07/07/182D 3D TSV
US9670220 66 Fused heterocyclic derivatives as S1P modulators Abbvie B.V.; AbbiVie Inc. 07/07/182D 3D TSV
US9670203 142 Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors BeiGene, Ltd. 07/07/182D 3D TSV
US9670212 191 Inhibitors of PI3K-delta and methods of their use and manufacture Exelixis, Inc. 07/07/182D 3D TSV
US9670209 69 Muscarinic agonists ACADIA PHARMACEUTICALS INC.; ALLERGAN, INC. 07/07/182D 3D TSV
US9670213 175 Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitor East China University of Science and Technology 07/07/182D 3D TSV
US9670208 48 Serine/threonine kinase inhibitors Array BioPharma Inc.; Genentech, Inc. 07/07/182D 3D TSV
US9670214 404 Small molecule myristate inhibitors of Bcr-abl and methods of use DANA-FARBER CANCER INSTITUTE, INC.; THE SCRIPPS RESEARCH INSTITUTE 07/07/182D 3D TSV
US9670136 210 (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors ORYZON GENOMICS S.A. 05/19/182D 3D TSV
US9670142 171 1,3-diaminocyclopentane carboxamide derivatives Merck Patent GmbH 05/19/182D 3D TSV
US9669034 227 4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group BAYER INTELLECTUAL PROPERTY GMBH 05/19/182D 3D TSV
US9670161 20 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group BAYER PHARMA AKTIENGESELLSCHAFT 05/19/182D 3D TSV
US9670157 271 Benzylamine derivatives Kalvista Pharmaceuticals Limited 05/19/182D 3D TSV
US9669035 66 Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disorders JANSSEN PHARMACEUTICA NV 05/19/182D 3D TSV
US9669095 13 Cyclosporin analogues for preventing or treating hepatitis C infection ENANTA PHARMACEUTICALS, INC. 05/19/182D 3D TSV
US9670195 3 Glycosidase inhibitors and uses thereof Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. 05/19/182D 3D TSV
US9669029 114 Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors H. Lundbeck A/S 05/19/182D 3D TSV
US9669031 313 MNK inhibitors and methods related thereto eFFECTOR THERAPEUTICS, INC. 05/19/182D 3D TSV
US9670201 104 Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof Pfizer Inc. 05/19/182D 3D TSV
US9670191 116 Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 05/19/182D 3D TSV
US9669028 175 Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors ARRIEN PHARMACEUTICALS LLC 05/19/182D 3D TSV
US9670181 87 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) ALLERGAN, INC.; EXONHIT THERAPEUTICS SA 05/19/182D 3D TSV
US9670194 71 Substituted aminopyrimidine compounds and methods of use CALITOR SCIENCES, LLC; SUNSHINE LAKE PHARMA CO., LTD. 05/19/182D 3D TSV
US9670166 297 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity Boehringer Ingelheim International GmbH 05/19/182D 3D TSV
US9670202 22 Substituted triazolopyridines BAYER PHARMA AKTIENGESELLSCHAFT 05/19/182D 3D TSV
US9670196 13 Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase inhibitors Merck Sharp & Dohme Corp. 05/19/182D 3D TSV
US9670193 138 Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease Novartis AG 05/19/182D 3D TSV
US9676728 19 2-benzyl-benzimidazole complement factor B inhibitors and uses thereof Novartis AG 04/16/182D 3D TSV
US9675697 203 BET bromodomain inhibitors and therapeutic methods using the same THE REGENTS OF THE UNIVERSITY OF MICHIGAN 04/16/182D 3D TSV
US9676721 112 Compounds and compositions for the inhibition of NAMPT FORMA TM, LLC 04/16/182D 3D TSV
US9676701 287 Cyclopropylamine derivatives useful as LSD1 inhibitors ORYZON GENOMICS, S.A. 04/16/182D 3D TSV
US9676732 74 Ethynyl derivatives HOFFMANN-LA ROCHE INC. 04/16/182D 3D TSV
US9676712 15 Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions CAYMAN CHEMICAL COMPANY, INC. 04/16/182D 3D TSV
US9676720 29 Substituted biaryl compound UBE INDUSTRIES, LTD. 04/16/182D 3D TSV
US9675616 13 Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-C]quinolines BAYER INTELLECTUAL PROPERTY GMBH 04/12/182D 3D TSV
US9688710 328 Inhibitors of sodium glucose cotransporter 1 Lexicon Pharmaceuticals, Inc. 04/12/182D 3D TSV
US9675614 334 PRMT5 inhibitors and uses thereof Epizyme, Inc. 04/12/182D 3D TSV
US9688696 116 Piperidine/piperazine derivatives Janssen Pharmaceutica N.V. 04/12/182D 3D TSV
US9688816 46 Polyetherimide compositions and methods for the manufacture and use thereof SABIC GLOBAL TECHNOLOGIES B.V. 04/12/182D 3D TSV
US9675612 45 Substituted thiazolopyrimidines BAYER PHARMA AKTIENGESELLSCHAFT 04/12/182D 3D TSV
US9688680 950 Compositions useful for treating disorders related to kit BLUEPRINT MEDICINES CORPORATION 03/27/182D 3D TSV
US9688695 384 Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation BRISTOL-MYERS SQUIBB COMPANY 03/27/182D 3D TSV
US9688678 37 Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseases AbbVie Deutschland GmbH & Co. KG 03/27/182D 3D TSV
US9688683 31 Substituted condensed pyrimidine compounds Dalhousie University 03/27/182D 3D TSV
US9688684 278 Substituted tetrazolo[1,5-a]pyrazines as ROR-gamma inhibitors Merck Patent GmbH 03/27/182D 3D TSV
US9688676 65 Tyrosine kinase inhibitors PRINCIPIA BIOPHARMA INC. 03/27/182D 3D TSV
US9688672 450 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH NOVARTIS AG 03/19/182D 3D TSV
US9688668 150 Long chain base sphingosine kinase inhibitors University of Virginia Patent Foundation 03/19/182D 3D TSV
US9688664 8 Modulators of fatty acid amide hydrolase Janssen Pharmaceutica NV 03/19/182D 3D TSV
US9688669 125 Oxazolidinones as modulators of mGluR5 Bristol-Myers Squibb Company 03/19/182D 3D TSV
US9688661 139 Substituted pyrroles active as kinases inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 03/19/182D 3D TSV
US9675593 518 Anti-fibrotic pyridinones INTERMUNE, Inc. 03/16/182D 3D TSV
US9675594 46 Arylpyrrolopyridine derived compounds as LRRK2 inhibitors H. Lundbeck A/S 03/16/182D 3D TSV
US9675539 2 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives Duke University 03/16/182D 3D TSV
US9675571 28 Inhibitors of indoleamine 2,3-dioxygenase (IDO) Bristol-Myers Squibb Company 03/16/182D 3D TSV
US9688645 25 Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa SANOFI 03/16/182D 3D TSV
US9675591 9 Methods for treating seizure disorders and pain SRMLSC 03/16/182D 3D TSV
US9675605 83 Substituted naphthyridine and quinoline compounds as MAO inhibitors Dart NeuroScience (Cayman) Ltd. 03/16/182D 3D TSV
US9688642 96 Substituted pyrazines as GPR40 agonists Janssen Pharmaceutica NV 03/12/182D 3D TSV
US9688643 325 Triazine derivative and pharmaceutical composition comprising the same SHIONOGI & CO., LTD. 03/12/182D 3D TSV
US9688638 35 Opioid agonists and uses thereof Nektar Therapeutics 03/11/182D 3D TSV
US9682995 359 Amino-substituted isothiazoles BAYER PHARMA AKTIENGESELLSCHAFT 03/10/182D 3D TSV
US9682993 22 Anticancer compounds St. Jude Children's Research Hospital 03/10/182D 3D TSV
US9682983 326 BMP inhibitors and methods of use thereof The Brigham and Women's Hospital, Inc.; Dept. of Health and Human Services, National Institutes of Health 03/10/182D 3D TSV
US9688615 706 Benzimidazole inhibitors of the sodium channel DEGIACOMO, INTERIM TRUSTEE, MARK G. 03/10/182D 3D TSV
US9688624 12 DP2 antagonist and uses thereof Brickell Biotech, Inc. 03/10/182D 3D TSV
US9687494 21 Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use Ambit Biosciences 03/10/182D 3D TSV
US9688629 262 Indole carboxamide compounds Bristol-Myers Squibb Company 03/10/182D 3D TSV
US9687479 520 Multisubstituted aromatic compounds as serine protease inhibitors VERSEON CORPORATION 03/10/182D 3D TSV
US9687478 34 Quinuclidine derivatives and medicinal compositions containing the same ALMIRALL, S.A. 03/10/182D 3D TSV
US9687483 5 Treatment of cerebral cavernous malformations and cerebral aneurysms with Rho kinase inhibitors BIOAXONE BIOSCIENCES, INC. 03/10/182D 3D TSV
US9682991 198 Tricyclic compounds for use as kinase inhibitors FUNDACIÓN CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III 03/10/182D 3D TSV
US9682971 220 1,2,5-Substituted benzimidazoles as flap modulators JANSSEN PHARMACEUTICA NV 02/14/182D 3D TSV
US9682980 85 Positive allosteric modulators of mGluR2 Bristol-Myers Squibb Company 02/14/182D 3D TSV
US9682976 324 Protein kinase C inhibitors and uses thereof Rigel Pharmaceuticals, Inc. 02/14/182D 3D TSV
US9682959 6 Ethynyl derivatives HOFFMANN-LA ROCHE INC. 02/13/182D 3D TSV
US9682965 75 Fumagillol heterocyclic compounds and methods of making and using same Zafgen, Inc. 02/13/182D 3D TSV
US9682966 563 Kappa opioid ligands The Scripps Research Institute 02/13/182D 3D TSV
US9682967 50 N-substituted-5-substituted phthalamic acids as sortilin inhibitors H. Lundbeck A/S 02/13/182D 3D TSV
US9682960 137 Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety ENDORECHERCHE, INC. 02/13/182D 3D TSV
US9682969 31 Phthalazinone compounds and methods for the treatment of cystic fibrosis Flatley Discovery Lab, LLC 02/13/182D 3D TSV
US9682968 110 Piperidinyl-indole derivatives complement factor B inhibitors and uses thereof Novartis AG 02/13/182D 3D TSV
US9682963 28 Pyridine derivatives as soft rock inhibitors Redx Pharma PLC 02/13/182D 3D TSV
US9682961 26 Quinazoline derivative CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER 02/13/182D 3D TSV
US9682953 166 Amide compounds, compositions and applications thereof ADVINUS THERAPEUTICS LIMITED 02/07/182D 3D TSV
US9687476 60 Bisaryl-bonded aryltriazolones and use thereof Bayer Intellectual Property GmbH 02/07/182D 3D TSV
US9682141 2516 Combination of kinase inhibitors and uses thereof Intellikine LLC 02/07/182D 3D TSV
US9682957 192 Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity Theravance Respiratory Company, LLC 02/07/182D 3D TSV
US9682940 502 Indazole derivatives useful as CB-1 inverse agonists Janssen Pharmaceutica NV 02/07/182D 3D TSV
US9682955 280 Quinazoline derivatives useful as CB-1 inverse agonists Janssen Pharmaceutica NV 02/07/182D 3D TSV
US9682910 35 Series of skin-whitening (lightening) compounds Unigen, Inc. 02/07/182D 3D TSV
US9695195 162 5-HT3 receptor antagonists Takeda Pharmaceutical Company Limited 02/06/182D 3D TSV
US9695205 53 Amide compounds for treatment of complement mediated disorders Achillion Pharmaceuticals, Inc. 02/06/182D 3D TSV
US9695197 11 Glycosidase inhibitors and uses thereof Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. 02/06/182D 3D TSV
US9695200 175 Heterocyclic ITK inhibitors for treating inflammation and cancer Confluence Life Sciences, Inc. 02/06/182D 3D TSV
US9695151 90 3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds Hoffmann-La Roche Inc. 01/26/182D 3D TSV
US9695152 84 3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds Hoffmann-La Roche Inc. 01/26/182D 3D TSV
US9695194 126 Benzoxazinone derivatives for treatment of skin diseases SIXERA PHARMA AB 01/26/182D 3D TSV
US9695172 15 Diazepane derivatives and uses thereof Dana-Farber Cancer Institute, Inc. 01/26/182D 3D TSV
US9695175 51 Highly selective c-Met inhibitors as anticancer agents CB THERAPEUTICS INC. 01/26/182D 3D TSV
US9695181 15 Hydroximic acid derivatives and medical applications therof DOUBLE RIDER MEDICINE CO., LTD. 01/26/182D 3D TSV
US9695174 21 Inhibitor of breast cancer resistance protein (BCRP) Millennium Pharmaceuticals, Inc. 01/26/182D 3D TSV
US9695165 82 Inhibitors of the fibroblast growth factor receptor BLUEPRINT MEDICINES CORPORATION 01/26/182D 3D TSV
US9695179 17 Methods and compositions for inhibition of bromodomain-containing proteins ConverGene LLC 01/26/182D 3D TSV
US9695170 217 Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) hydroxylase FibroGen, Inc. 01/26/182D 3D TSV
US9695160 36 Piperazine derivatives for treating disorders The University of Nottingham; NewSouth Innovations PTY Limited 01/26/182D 3D TSV
US9695183 702 Substituted 7-azabicycles and their use as orexin receptor modulators JANSSEN PHARMACEUTICA NV 01/26/182D 3D TSV
US9695180 119 Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors Incyte Corporation 01/26/182D 3D TSV
US9695168 158 Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors Incyte Corporation 01/26/182D 3D TSV
US9695176 4 Substituted imidazo[1,5-a]pyrazines as CGRP receptor antagonists Bristol-Myers Squibb Company 01/26/182D 3D TSV
US9695167 13 Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors Incyte Corporation 01/26/182D 3D TSV
US9695185 5 Synthetic methods for spiro-oxindole compounds Xenon Pharmaceuticals Inc. 01/26/182D 3D TSV
US9695163 76 Thiazole orexin receptor antagonists MERCK SHARP & DOHME CORP 01/26/182D 3D TSV
US9695149 235 1,2,6-substituted benzimidazoles as flap modulators JANSSEN PHARMACEUTICA NV 01/19/182D 3D TSV
US9695118 394 Benzamide derivative Chugai Seiyaku Kabushiki Kaisha 01/19/182D 3D TSV
US9694016 2555 Biaryl amide compounds as kinase inhibitors NOVARTIS AG 01/19/182D 3D TSV
US9695128 13 Ethynyl derivatives Hoffmann-La Roche Inc. 01/19/182D 3D TSV
US9695132 194 Heteroaryl compounds and uses thereof Celgene CAR LLC; Sanofi 01/19/182D 3D TSV
US9694018 12 IBAT inhibitors for the treatment of liver disease Albireo AB 01/19/182D 3D TSV
US9694015 59 Methods for the treatment of locally advanced breast cancer Celgene Corporation 01/19/182D 3D TSV
US9694024 17 Methods of treating retroviral infections and related dosage regimes Chimerix, Inc. 01/19/182D 3D TSV
US9694012 76 Pyrazol derivatives Hoffmann-La Roche Inc. 01/19/182D 3D TSV
US9694011 6 Substituted pyrazolopyrimidines as kinases inhibitors Jiangsu Medolution Ltd 01/19/182D 3D TSV
US9695131 56 Substituted uracils as chymase inhibitors Bayer Pharma Aktiengesellschaft 01/19/182D 3D TSV
US9693997 356 Antiviral compounds HOFFMANN-LA ROCHE INC. 01/14/182D 3D TSV
US9693992 251 IRE-1α inhibitors MannKind Corporation 01/14/182D 3D TSV
US9694002 648 Substituted benzamides and methods of use thereof GENENTECH, INC.; XENON PHARMACEUTICALS INC. 01/14/182D 3D TSV
US9527838 54 2-pyridinecarboxamide derivatives, compositions containing such compounds, and methods of treatment Merck Sharp & Dohme Corp. 12/04/172D 3D TSV
US9527839 25 Benzimidazole tetrahydropyran derivatives Merck Sharp & Dohme Corp. 12/04/172D 3D TSV
US9533969 6 Materials and method for inhibiting replication protein A and uses thereof Indiana University Research and Technology Corporation 12/04/172D 3D TSV
US9532990 119 Polyfluorinated compounds acting as bruton tyrosine kinase inhibitors Zhejiang DTRM Biopharma Co. Ltd. 12/04/172D 3D TSV
US9504692 48 Selective inhibition of MALT1 protease by phenothiazine derivatives HELMHOLTZ ZENTRUM MUNCHEN, DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT (GMBH) 12/04/172D 3D TSV
US9533989 123 Substituted pyrimidine-5-carboxamides as spleen tyrosine kinase inhibitors Ziarco Pharma Ltd. 12/04/172D 3D TSV
US9533985 193 Sulfonamide derivative and medicinal use thereof EA Pharma Co., Ltd. 12/04/172D 3D TSV
US9522881 71 Hydroxyindole carboxylic acid based inhibitors for oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) Indiana University Research and Technology Corporation 11/27/172D 3D TSV
US9512115 58 Inhibitors PROBIODRUG AG 11/27/172D 3D TSV
US9505766 158 Kinase inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 11/27/172D 3D TSV
US9522910 16 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYOU “FUSION PHARMA” 11/27/172D 3D TSV
US9505762 338 Purine derivatives as CB2 receptor agonists HOFFMANN-LA ROCHE INC. 11/27/172D 3D TSV
US9512141 84 Pyrazine derivatives as CB2 receptor agonists HOFFMANN-LA ROCHE INC. 11/27/172D 3D TSV
US9512132 76 Pyrazole compounds as CB2 agonists Hoffmann-La Roche Inc. 11/27/172D 3D TSV
US9522886 195 Pyridine derivatives HOFFMANN-LA ROCHE INC. 11/27/172D 3D TSV
US9505749 527 Quinazolinone compounds and derivatives thereof AMGEN INC. 11/27/172D 3D TSV
US9505780 114 Thienopyranones as kinase and epigenetic inhibitors SignalRx Pharmaceuticals, Inc. 11/27/172D 3D TSV
US9512121 47 [1,2,4] triazol [4,3-A] pyridine derivative, preparation method therefor or medical application thereof Jiangsu Hansoh Pharmaceutical Co., Ltd. 11/27/172D 3D TSV
US9499492 130 4-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group Bayer Pharma Aktiengesellschaft 11/20/172D 3D TSV
US9499502 733 5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 11/20/172D 3D TSV
US9512084 40 Amino pyrimidine derivatives Novartis AG 11/20/172D 3D TSV
US9499547 110 Amino-substituted imidazopyridazines BAYER INTELLECTUAL PROPERTY GMBH 11/20/172D 3D TSV
US9493490 60 Boron-containing small molecules Anacor Pharmaceuticals, Inc. 11/20/172D 3D TSV
US9493486 113 Diazaspirocycloalkane and azaspirocycloalkane Hoffmann-La Roches Inc. 11/20/172D 3D TSV
US9505745 110 Enhancer of zeste homolog 2 inhibitors GlaxoSmithKline Intellectual Property (No. 2) Limited 11/20/172D 3D TSV
US9526727 30 Inhibitors of beta-secretase Vitae Pharmaceutical, Inc. 11/20/172D 3D TSV
US9499482 247 Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists Bristol-Myers Squibb Company 11/20/172D 3D TSV
US9512114 52 Substituted aminopyrimidine compounds and methods of use CALITOR SCIENCES, LLC; SUNSHINE LAKE PHARMA CO., LTD. 11/20/172D 3D TSV
US9512126 25 Substituted imidazopyridazines Bayer Intellectual Property GmbH 11/20/172D 3D TSV
US9512169 23 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments BAYER PHARMA AKTIENGESELLSCHAFT 11/13/172D 3D TSV
US9512068 14 Augmenting moieties for anti-inflammatory compounds RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY; LEHIGH UNIVERSITY 11/13/172D 3D TSV
US9493448 168 Cycloalkane derivatives DAIICHI SANKYO COMPANY, LIMITED 11/13/172D 3D TSV
US9511061 6 Incontinence treatment methods IXALTIS 11/13/172D 3D TSV
US9505753 69 Inhibitors of D-amino acid oxidase THE JOHNS HOPKINS UNIVERSITY 11/13/172D 3D TSV
US9512082 7 Inhibitors of glutaminyl cyclase PROBIODRUG AG 11/13/172D 3D TSV
US9493446 1134 Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives ACTELION PHARMACEUTICALS LTD. 11/13/172D 3D TSV
US9512065 5 Polymorphs of N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide hydrochloride Kalvista Pharmaceuticals Limited 11/13/172D 3D TSV
US9493485 178 Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereof Imago Pharmaceuticals, Inc. 11/13/172D 3D TSV
US9505786 59 Substituted annulated triazines and use thereof BAYER PHARMA AKTIENGESELLSCHAFT; BAYER INTELLECTUAL PROPERTY GMBH 11/13/172D 3D TSV
US9522888 952 Substituted bicyclic compounds Bristol-Myers Squibb Company 11/13/172D 3D TSV
US9512130 4 Substituted imidazopyridazines BAYER PHARMA AKTIENGESELLSCHAFT 11/13/172D 3D TSV
US9493441 222 Acyclic cyanoethylpyrazoles as janus kinase inhibitors Merck Sharp & Dohme Corp. 11/06/172D 3D TSV
US9489013 194 C6-azaspiro iminothiadiazine dioxides as bace inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 11/06/172D 3D TSV
US9493440 239 Compounds inhibiting leucine-rich repeat kinase enzyme activity Merck Sharp & Dohme Corp. 11/06/172D 3D TSV
US9493432 214 Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders Takeda Pharmaceuticals Company Limited 11/06/172D 3D TSV
US9487511 375 Cyclopropanamine compound and use thereof Takeda Pharmaceutical Company Limited 11/06/172D 3D TSV
US9522883 1 Glycosidase inhibitors and uses thereof Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. 11/06/172D 3D TSV
US9505736 16 Histone deacetylase inhibitors and compositions and methods of use thereof CHDI Foundation, Inc. 11/06/172D 3D TSV
US9493435 182 IRE-1α inhibitors MannKing Corporation 11/06/172D 3D TSV
US9492453 77 Protein kinase B inhibitors AstraZeneca AB 11/06/172D 3D TSV
US9505773 18 Rapamycin analogues and their pharmaceutical use Isomerase Therapeutics Ltd. 11/06/172D 3D TSV
US9504684 11 Syk inhibitors Gilead Sciences, Inc. 11/06/172D 3D TSV
US9487512 159 (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Oryzon Genomics S.A. 10/30/172D 3D TSV
US9487490 63 3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereof Merck Sharp & Dohme Corp. 10/30/172D 3D TSV
US9481672 253 Bicyclically substituted uracils and the use thereof Bayer Pharma Aktiengesellschaft 10/30/172D 3D TSV
US9487483 128 Complement pathway modulators and uses thereof Novartis AG 10/30/172D 3D TSV
US9505754 4 Compound useful for the treatment of degenerative and inflammatory diseases GALAPAGOS NV 10/30/172D 3D TSV
US9487462 114 Inhibitors of matrix metalloproteinases PharmaHungary 2000 Kft.; TargetEx Kft. 10/30/172D 3D TSV
US9481648 347 Kinase inhibitors Respivert Limited; Topivert Pharma Limited 10/30/172D 3D TSV
US9505743 3 Matrix metalloproteinase inhibitors and methods for the treatment of pain and other diseases TBA 10/30/172D 3D TSV
US9487501 114 Pyrazole carboxamide compounds and uses thereof Hoffmann-La Roche Inc. 10/30/172D 3D TSV
US9475815 228 Substituted benzothienyl-pyrrolotriazines and uses thereof BAYER INTELLETUAL PROPERTY GMBH 10/30/172D 3D TSV
US9487488 60 Sulfonamide compound MITSUBISHI TANABE PHARMA CORPORATION 10/30/172D 3D TSV
US9481688 24 (Thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT2A antagonists Eli Lilly and Company 10/23/172D 3D TSV
US9499493 51 2,4-pyrimidinediamine compounds and their uses Rigel Pharmaceuticals, Inc. 10/23/172D 3D TSV
US9499570 14 Boron containing small molecules Anacor Pharmaceuticals, Inc. 10/23/172D 3D TSV
US9499561 46 Fused pyrimidine compound, and preparation method, intermediate, composition, and uses thereof Shanghai Yingli Pharmaceutical Co., Ltd. 10/23/172D 3D TSV
US9499486 7 Kinase inhibitor Respivert Limited; Topivert Pharma Limited 10/23/172D 3D TSV
US9499523 63 Phosphatidylinositol 3-kinase inhibitors GILEAD SCIENCES, INC. 10/23/172D 3D TSV
US9475817 402 Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors Bristol-Myers Squibb Company 10/23/172D 3D TSV
US9475819 702 Substituted 7-azabicycles and their use as orexin receptor modulators Janssen Pharmaceutica NV 10/23/172D 3D TSV
US9481682 221 Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors MERCK SHARP & DOHME CORP. 10/23/172D 3D TSV
US9499534 42 Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors Merck Sharp & Dohme Corp. 10/23/172D 3D TSV
US9475813 268 Tricyclic pyrrolopyridine compound, and JAK inhibitor Nissan Chemical Industries, Ltd. 10/23/172D 3D TSV
US9469597 210 (Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Oryzon Genomics S.A. 10/16/172D 3D TSV
US9505765 36 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatment CONFLUENCE LIFE SCIENCES INC. 10/16/172D 3D TSV
US9499542 46 Arylpyrrolopyridine derived compounds as LRRK2 inhibitors H. Lundbeck A/S; Vernalis (R&D) Ltd. 10/16/172D 3D TSV
US9475775 160 Benzazepine dicarboxamide compounds Hoffmann-La Roche Inc. 10/16/172D 3D TSV
US9493483 6 Benzo [C] isoxazoloazepine bromodomain inhibitors and uses thereof Constellation Pharmaceuticals, Inc. 10/16/172D 3D TSV
US9487554 62 Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical preparations comprising them and their use for preparing medicaments Bayer Intellectual Property GmbH; Bayer Pharma Aktiengesellschaft 10/16/172D 3D TSV
US9469631 130 N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them, and uses thereof Boehringer Ingelheim International GmbH 10/16/172D 3D TSV
US9464084 843 P2X7 modulators Janssen Pharmaceutica NV 10/16/172D 3D TSV
US9505734 2 Phenyl C-glucoside derivative containing deoxyglucose structure, preparation method and use thereof Tianjin Institute of Pharmaceutical Research 10/16/172D 3D TSV
US9468661 123 Pyrrolidine derivatives and their use as complement pathway modulators Novartis AG 10/16/172D 3D TSV
US9493412 34 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors Bristol-Myers Squibb Company 10/16/172D 3D TSV
US9493472 34 Substituted benzoxazoles Bayer Pharma Aktiengesellschaft 10/16/172D 3D TSV
US9481677 37 Biaryl ether sulfonamides and their use as therapeutic agents XENON PHARMACEUTICALS INC. 10/10/172D 3D TSV
US9493457 3 4,5,6,7-tetrahyroimidazo[4,5-c]pyridine compounds Proximagen Limited 10/09/172D 3D TSV
US9481673 141 6-alkynyl-pyridine derivatives Boehringer ingelheim International GmbH 10/09/172D 3D TSV
US9493431 44 Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases ABBVIE INC. 10/09/172D 3D TSV
US9493430 41 Biaryl- or heterocyclic biaryl-substituted cyclohexene derivative compounds as CETP inhibitors Chong Kun Dang Pharmaceutical Corp. 10/09/172D 3D TSV
US9493474 60 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 10/09/172D 3D TSV
US9458201 162 Melanocortin receptor-specific heptapeptides Palatin Technologies, Inc. 10/09/172D 3D TSV
US9458171 572 Pyrrolidinyl sulfone RORγ modulators Bristol-Myers Squibb Company 10/09/172D 3D TSV
US9505739 11 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease Merck Sharp & Dohme Corp. 10/09/172D 3D TSV
US9464092 229 Transient protection of normal cells during chemotherapy G1 Therapeutics, Inc. 10/09/172D 3D TSV
US9459250 254 Use of T1R3 venus flytrap region polypeptide to screen for taste modulators SENOMYX, INC. 10/09/172D 3D TSV
US9464076 131 Benzothiophene derivative Daiichi Sankyo Company, Limited 10/02/172D 3D TSV
US9487494 9 Cyclic hydrocarbon compounds for the treatment of diseases LEO PHARMA A/S 10/02/172D 3D TSV
US9481685 8 Imaging neuroinflammation GE Healthcare Limited 10/02/172D 3D TSV
US9493447 14 Optically active PDE10 inhibitor Omeros Corporation 10/02/172D 3D TSV
US9480684 35 Orvinol and thevinol derivatives useful in the treatment of anxiety or a compulsive disorder The University of Bath 10/02/172D 3D TSV
US9458110 632 Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors Bristol-Myers Squibb Company 10/02/172D 3D TSV
US9458172 180 Pyridinyl and pyrimidinyl sulfoxide and sulfone derivatives TBA 10/02/172D 3D TSV
US9493429 9 Substituted benzoxazoles and methods of use thereof GENENTECH, INC.; XENON PHARMACEUTICALS INC. 10/02/172D 3D TSV
US9458113 187 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity Boehringer Ingelheim International GmbH 10/02/172D 3D TSV
US9458176 245 Tetrahydroimidazo(1,5-D)[1,4]oxazepine derivative Eisai R&D Management Co., Ltd. 10/02/172D 3D TSV
US9469608 44 Thrombin inhibitors Merck Sharp & Dohme Corp. 10/02/172D 3D TSV
US9452986 683 6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use AbbVie Inc. 09/25/172D 3D TSV
US9453031 272 Chemical entities Fundación Centro Nacional de Investigaciones Oncológicas Carlos III 09/25/172D 3D TSV
US9475814 83 Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof Euroscreen S.A. 09/25/172D 3D TSV
US9475806 21 Complement factor B inhibitors and uses there of Novartis AG 09/25/172D 3D TSV
US9452990 131 Complement pathway modulators and uses thereof NOVARTIS AG 09/25/172D 3D TSV
US9464060 136 Compounds Takeda Pharmaceutical Company Limited 09/25/172D 3D TSV
US9468642 46 Imidazopyrazines BAYER INTELLECTUAL PROPERTY GMBH 09/25/172D 3D TSV
US9447148 197 Melanocortin-1 receptor-specific cyclic peptides Palatin Technologies, Inc. 09/25/172D 3D TSV
US9469653 23 Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 09/25/172D 3D TSV
US9452998 274 Protein kinase C inhibitors and methods of their use NOVARTIS AG 09/25/172D 3D TSV
US9481668 1 Quinoline inhibitor of the macrophage stimulating 1 receptor MSTR1 Merck Patent GmbH 09/25/172D 3D TSV
US9475779 63 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity Boehringer Ingelheim International GmbH 09/25/172D 3D TSV
US9475809 16 Substituted oxopyridine derivatives and use thereof as factor xia/plasma Bayer Pharma Aktiengesellschaft 09/25/172D 3D TSV
US9469613 4 (N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide GILEAD SCIENCES, INC. 09/18/172D 3D TSV
US9464044 101 Compound having ability to inhibit 11Beta-HSD1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient AHN-GOOK PHARMACEUTICAL CO., LTD.; BAMICHEM CO., LTD; INCHEON UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION 09/18/172D 3D TSV
US9447087 91 Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders UNIVERSITY OF UTAH RESEARCH FOUNDATION 09/18/172D 3D TSV
US9469644 7 Inhibitors of Bruton's tyrosine kinase Hoffmann-La Roche Inc. 09/18/172D 3D TSV
US9469639 14 Naphthylurea derivatives and medical applications thereof Radiant Pharma & Tech. Co., Ltd. 09/18/172D 3D TSV
US9469627 3 Phenyloxadiazole derivatives as PGDS inhibitors Sanofi 09/18/172D 3D TSV
US9434697 144 Pyrimidine FGFR4 inhibitors EISAI R&D MANAGEMENT CO., LTD. 09/18/172D 3D TSV
US9464103 12 Spirocyclic sulfones as gamma secretase inhibitors MERCK SHARP & DOHME CORP. 09/18/172D 3D TSV
US9434727 247 Substituted 4-phenylpiperidines, their preparation and use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 09/18/172D 3D TSV
US9447038 205 Substituted B-amino acid derivatives as CXCR3 receptor antagonists Sanofi 09/18/172D 3D TSV
US9452980 625 Substituted benzamides Hoffmann-La Roche Inc. 09/18/172D 3D TSV
US9447106 218 Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators BeiGene, Ltd. 09/18/172D 3D TSV
US9475795 111 Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases Takeda Pharmaceutical Company Limited 09/18/172D 3D TSV
US9457039 24 2′-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp. 09/11/172D 3D TSV
US9434725 762 5-azaindazole compounds and methods of use F. HOFFMANN-LA ROCHE AG 09/11/172D 3D TSV
US9458145 111 Benzimidazole derivatives as bromodomain inhibitors Gilead Sciences, Inc. 09/11/172D 3D TSV
US9453034 72 C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 09/11/172D 3D TSV
US9458136 1 Crystalline forms and processes for the preparation of cannabinoid receptor modulators Arena Pharmaceuticals, Inc. 09/11/172D 3D TSV
US9458135 60 Dihydroquinoline-2-one derivatives Hoffmann-La Roche Inc. 09/11/172D 3D TSV
US9464062 6 Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2B activity modulators TEMPLE UNIVERSITY—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 09/11/172D 3D TSV
US9458140 29 Furanone compounds as kinase inhibitors Eternity Bioscience Inc. 09/11/172D 3D TSV
US9453038 42 Glucokinase activator compounds, compositions containing such compounds, and methods of treatment Merck Sharp & Dohme Corp. 09/11/172D 3D TSV
US9453048 38 IAP antagonists Bristol-Myers Squibb Company 09/11/172D 3D TSV
US9458105 10 Inhibitors of Bruton's tyrosine kinase Hoffmann-La Roche Inc. 09/11/172D 3D TSV
US9464073 16 Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors Acetylon Pharmaceuticals, Inc. 09/11/172D 3D TSV
US9464081 23 Pyrrolidine derivatives and their use as complement pathway modulators Novartis AG 09/11/172D 3D TSV
US9434711 709 Sulfonamides as TRPM8 modulators Janssen Pharmaceutica, N.V. 09/11/172D 3D TSV
US9463192 43 Trk-inhibiting compound ONO PHARMACEUTICAL CO., LTD. 09/11/172D 3D TSV
US9434719 783 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH NOVARTIS AG 09/05/172D 3D TSV
US9453017 12 Antiviral therapies with phospholipase D inhibitors Vanderbilt University 09/05/172D 3D TSV
US9447029 38 Fluorinated arylalkylaminocarboxamide derivatives NEWRON PHARMACEUTICALS S.P.A. 09/05/172D 3D TSV
US9447090 34 Imidazopyridine compounds Astellas Pharma Inc. 09/05/172D 3D TSV
US9447085 33 Iminothiadiazine dioxides containing a thioamide, amidine, or amide oxime group as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 09/05/172D 3D TSV
US9446026 20 Ocular formulations for drug-delivery to the posterior segment of the eye PanOptica, Inc. 09/05/172D 3D TSV
US9434733 75 PDE9 inhibitors with imidazo triazinone backbone H. LUNDBECK A/S 09/05/172D 3D TSV
US9447092 48 Pharmaceutically active compounds CANCER RESEARCH TECHNOLOGY LIMITED 09/05/172D 3D TSV
US9447091 40 Protein kinase inhibitors ORION CORPORATION 09/05/172D 3D TSV
US9447095 30 Pyrimidine derivatives as phosphodiesterase 10 inhibitors (PDE-10) PALOBIOFARMA S.L. 09/05/172D 3D TSV
US9453018 22 Pyrimidinones as factor XIa inhibitors Bristol-Myers Squibb Company 09/05/172D 3D TSV
US9453021 17 Pyrimidodiazepinone compound Kyowa Hakko Kirin Co., Ltd. 09/05/172D 3D TSV
US9434724 377 Quinuclidines for modulating alpha 7 activity ALPHARMAGEN, LLC 09/05/172D 3D TSV
US9453023 39 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof Sanofi 09/05/172D 3D TSV
US9452985 8 Tau imaging probe GE Healthcare Limited 09/05/172D 3D TSV
US9428508 324 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors Centaurus BioPharma Co., Ltd. 08/28/172D 3D TSV
US9446130 25 BTK inhibitors Merck Sharp & Dohme Corp. 08/28/172D 3D TSV
US9433609 144 Benzimidazole-imidazole derivatives Janssen Sciences Ireland UC 08/28/172D 3D TSV
US9428514 208 Bromodomain inhibitors AbbVie Inc. 08/28/172D 3D TSV
US9446044 107 DYRK1 inhibitors and uses thereof DIAXONHIT 08/28/172D 3D TSV
US9447132 2 Highly active nucleoside derivative for the treatment of HCV Achillion Pharmaceuticals, Inc. 08/28/172D 3D TSV
US9428503 315 Imidazo[4,5-c]quinolin-2-one compounds and their use in treating Cancer AstraZeneca AB 08/28/172D 3D TSV
US9428511 152 Imidazopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Bristol-Myers Squibb Company 08/28/172D 3D TSV
US9434692 4 Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto Arena Pharmaceuticals, Inc. 08/28/172D 3D TSV
US9433622 330 Pyrimidine compounds useful in the treatment of diseases mediated by IKKE and/or TBK1 mechanisms Case Western Reserve University 08/28/172D 3D TSV
US9447057 29 Schiff bases of thiazoles: a new class of ureases inhibitors TBA 08/28/172D 3D TSV
US9434690 357 Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders Bayer Pharma Aktiengesellschaft 08/28/172D 3D TSV
US9434693 45 Substituted pyrazoles as N-type calcium channel blockers Janssen Pharmaceutica NV 08/28/172D 3D TSV
US9447114 29 Thieno- and furo[2,3-d]pyrimidine-2,4[1H,3H]-dione derivatives Hydra Biosciences, Inc. 08/28/172D 3D TSV
US9428513 29 Triazolopyrazine Boehringer Ingelheim International GmbH 08/28/172D 3D TSV
US9428505 22 Hydantoin derivative Chugai Seiyaku Kabushiki Kaisha 08/24/172D 3D TSV
US9428469 30 Antiviral compounds HOFFMANN-LA ROCHE 08/22/172D 3D TSV
US9447055 2 α-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof Merck Serono S.A. 08/21/172D 3D TSV
US9428456 501 1-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivatives ACTELION PHARMACEUTICALS LTD 08/21/172D 3D TSV
US9428504 172 7-hydroxy-spiropipiperidine indolinyl antagonists of P2Y1 receptor Bristol-Myers Squibb Company 08/21/172D 3D TSV
US9428500 117 Alpha-carbolines for the treatment of cancer UNIVERSITA DEGLI STUDI DI MILANO—BICOCCA; UNIVERSITE DE GENEVE; UNIVERSITE CLAUDE BERNARD—LYON 08/21/172D 3D TSV
US9427428 138 Benzimidazole-imidazole derivatives Janssen Sciences Ireland UC 08/21/172D 3D TSV
US9428501 53 Bicyclic nitrogen-containing aromatic heterocyclic amide compound Astellas Pharma Inc. 08/21/172D 3D TSV
US9446064 9 Combination therapy for treating cancer Epizyme, Inc. 08/21/172D 3D TSV
US9428502 338 Heterocyclic modulators of lipid synthesis 3-V Biosciences, Inc. 08/21/172D 3D TSV
US9427440 69 Macrocyclic indole derivatives useful as hepatitis C virus inhibitors Janssen Sciences Ireland UC 08/21/172D 3D TSV
US9428460 40 N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products BAYER PHARMA AKTIENGESELLSCHAFT 08/21/172D 3D TSV
US9428478 66 Piperazine derivatives, compositions, and uses related thereto Emory University 08/21/172D 3D TSV
US9428476 17 S-imino-S-oxo-iminothiadiazine compounds as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 08/21/172D 3D TSV
US9428492 54 Secondary alcohol substituted triazoles as PDE10 inhibitors Merck Sharp & Dohme Corp. 08/21/172D 3D TSV
US9428491 12 Substituted azoles, antiviral active component, pharmaceutical composition, method for preparation and use thereof TBA 08/21/172D 3D TSV
US9422293 771 Tetrahydro-pyrimidoazepines as modulators of TRPV1 Janssen Pharmaceutica NV 08/21/172D 3D TSV
US9422331 108 2-oxo-2,3,4,5-tetrahydro-1 H-benzo[B]diazepines and their use in the treatment of cancer HOFFMANN-LA ROCHE INC. 08/14/172D 3D TSV
US9422332 92 Azaheterocycles as BIR2 and/or BIR3 inhibitors HOFFMANN-LA ROCHE INC. 08/14/172D 3D TSV
US9428447 29 Bis-(aryl/heteroaryl)-methylene compounds, pharmaceutical compositions containing same and their use for treating cancer The Royal Institution for the Advancement of Learning/McGill University 08/14/172D 3D TSV
US9415055 223 Cyclic amines H. Lundbeck A/S 08/14/172D 3D TSV
US9422318 37 Epoxyeicosatrienoic acid analogs and methods of making and using the same The Medical College of Wisconsin, Inc.; The Board of Regents of the University of Texas System 08/14/172D 3D TSV
US9427442 58 Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds Bristol-Myers Squibb Company 08/14/172D 3D TSV
US9422240 52 Partially saturated nitrogen-containing heterocyclic compound TAISHO PHARMACEUTICAL CO., LTD 08/14/172D 3D TSV
US9422255 40 S-imino-S-oxo-iminothiazine compounds as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 08/14/172D 3D TSV
US9422299 205 Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists EUROSCREEN SA 08/14/172D 3D TSV
US9416132 120 Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors Tolero Pharmaceuticals, Inc. 08/14/172D 3D TSV
US9422235 171 Sulfonamide derivatives with therapeutic indications Pharmos Corporation 08/14/172D 3D TSV
US9422290 38 Triazolopyridazine Boehringer Ingelheim International GmbH 08/14/172D 3D TSV
US9422297 65 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof Duquesne University of the Holy Ghost 08/14/172D 3D TSV
US9416129 244 Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use Merck Sharp & Dohme Corp. 08/14/172D 3D TSV
US9422277 170 Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use Merck Sharp & Dohme Corp. 08/14/172D 3D TSV
US9394331 44 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections Gilead Pharmasset LLC 08/07/172D 3D TSV
US9409892 368 4-hydroxy-isoquinoline compounds as HIF hydroxylase inhibitors FibroGen, Inc. 08/07/172D 3D TSV
US9416154 45 5′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp. 08/07/172D 3D TSV
US9428465 17 Acid ceramidase inhibitors and their use as medicaments Fondazione Istituto Italiano Di Technologia 08/07/172D 3D TSV
US9409895 69 Autotaxin inhibitors Novartis AG 08/07/172D 3D TSV
US9409908 443 Dihydropyridone p1 as factor XIa inhibitors Bristol-Myers Squibb Company 08/07/172D 3D TSV
US9409888 53 Dimeric compounds Hoffmann-La Roche Inc. 08/07/172D 3D TSV
US9422333 28 HCV protease inhibitors and uses thereof Celgene Avilomics Research, Inc. 08/07/172D 3D TSV
US9409917 118 Heterocyclic amide derivatives as P2X7 receptor antagonists ACTELION PHARMACEUTICALS LTD. 08/07/172D 3D TSV
US9421177 72 Imidamide sphingosine kinase inhibitors University of Virginia Patent Foundation 08/07/172D 3D TSV
US9409907 205 Inhibitor compounds Cancer Research Technology Limited 08/07/172D 3D TSV
US9416123 85 Kinase modulators for the treatment of cancer Synovo GmbH 08/07/172D 3D TSV
US9428466 9 Methods for reducing uric acid levels using barbiturate derivatives TBA 08/07/172D 3D TSV
US9416139 72 Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof SUNSHINE LAKE PHARMA CO., LTD. 08/07/172D 3D TSV
US9409915 90 Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators Janssen Pharmaceutica NV 08/07/172D 3D TSV
US9422307 17 2,4,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 08/01/172D 3D TSV
US9422324 8 6-substituted demethyl-estradiol derivatives as selective ER-β agonists Endece LLC 08/01/172D 3D TSV
US9422312 21 Azabenzimidazole derivatives Boehringer Ingelheim International GmbH 08/01/172D 3D TSV
US9422273 40 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response ALLERGAN, INC. 08/01/172D 3D TSV
US9422243 55 3-phenyl-isoquinolin-1(2H)-one derivatives as PARP-1 inhibitors NERVIANO MEDICAL SCIENCES S.R.L. a corporation 07/31/172D 3D TSV
US9403813 270 Azetidine amide derivatives as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD. 07/31/172D 3D TSV
US9403843 72 Cysteine protease inhibitors and uses thereof THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK; THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 07/31/172D 3D TSV
US9422263 19 Fluoro-substituted 3,5-dicyano-4-(1H-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof BAYER PHARMA AKTIENGESELLSCHAFT 07/31/172D 3D TSV
US9422261 11 Heterocyclic resorcinol derivatives, preparation of same and cosmetic uses thereof PIERRE FABRE DERMO-COSMETIQUE 07/31/172D 3D TSV
US9422231 5 Method for inhibiting Trypanosoma cruzi HOWARD UNIVERSITY 07/31/172D 3D TSV
US9403808 195 Pyrazine derivatives Hoffmann-La Roche Inc. 07/31/172D 3D TSV
US9409882 96 Pyridine derivatives Hoffmann-La Roche Inc. 07/31/172D 3D TSV
US9409866 620 Pyridine-2-amides useful as CB2 agonists HOFFMANN-LA ROCHE INC. 07/31/172D 3D TSV
US9409924 26 Selective glycosidase inhibitors and uses thereof Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. 07/31/172D 3D TSV
US9403767 182 Substituted 4-aminocyclohexane derivatives GRUENENTHAL GMBH 07/31/172D 3D TSV
US9403801 81 Substituted heteroaryl compounds and methods of use CALITOR SCIENCES, LLC; SUNSHINE LAKE PHARMA CO., LTD. 07/31/172D 3D TSV
US9394309 198 Substituted phenylimidazopyrazoles and their use Bayer Pharma Aktiengesellschaft; Bayer Intellectual Property GmbH 07/31/172D 3D TSV
US9416127 72 Triazole carboxamides and uses thereof Hoffmann-La Roche Inc. 07/31/172D 3D TSV
US9394311 136 Triazolo compounds as PDE10 inhibitors Hoffmann-La Roche Inc. 07/31/172D 3D TSV
US9403810 48 Carboxamide derivatives Novartis AG 07/25/172D 3D TSV
US9409931 8 3-O-acyl-ingenol analogues LEO LABORATORIES LIMITED 07/24/172D 3D TSV
US9408863 13 5′-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp. 07/24/172D 3D TSV
US9409845 22 Alpha-(3,5-dimethoxybenzylidene)-alpha′-hydrocarbyl methylene cyclic ketone and preparation method thereof PHARMAXYN LABORATORIES LTD. 07/24/172D 3D TSV
US9394297 934 Amides as pim inhibitors AMGEN INC. 07/24/172D 3D TSV
US9403846 28 Carbocyclic- and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 07/24/172D 3D TSV
US9403833 17 Carboxamide derivatives Novartis AG 07/24/172D 3D TSV
US9409900 4 Compound for increasing kinase active and application thereof FUJIAN HAIXI PHARMACEUTICALS, INC.; BETTA PHARMACUETICALS CO., LTD. 07/24/172D 3D TSV
US9416126 394 Compounds inhibiting leucine-rich repeat kinase enzyme activity Merck Sharp & Dohme Corp. 07/24/172D 3D TSV
US9403803 15 Indole-3-carboxamides as kinase inhibitors Allergan, Inc. 07/24/172D 3D TSV
US9403768 24 Indolines Hoffmann-La Roche Inc. 07/24/172D 3D TSV
US9409868 44 Inhibitors of rho associated protein kinases (ROCK) and methods of use H. Lee Moffin Cancer Center and Research Institute, Inc. 07/24/172D 3D TSV
US9409858 37 Selective histone deactylase 6 inhibitors H. Lee Moffitt Cancer Center and Research Institute, Inc.; Board of Trustees of the University of Illinois 07/24/172D 3D TSV
US9408850 74 Substituted indazole derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 07/24/172D 3D TSV
US9403827 32 Substituted purinone compounds NOVARTIS AG 07/24/172D 3D TSV
US9403831 42 Triazolopyrazine derivative and use thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY; HANDOK INC. 07/24/172D 3D TSV
US9416103 25 Use of the aminoalkylindole JWH-073-M4 and related compounds as neutral CB1 receptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases The Board of Trustees of the University of Arkansas; The University of Kansas 07/24/172D 3D TSV
US9394275 191 Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Theravance Respiratory Company, LLC 07/18/172D 3D TSV
US9394273 118 Therapeutic prostaglandin receptor agonists ALLERGAN, INC. 07/18/172D 3D TSV
US9403797 2 5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use Cancer Research Technology Limited 07/17/172D 3D TSV
US9394291 20 Benzoxazinone amides as mineralocorticoid receptor modulators AstraZeneca AB 07/17/172D 3D TSV
US9403774 6 Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors Bristol-Myers Squibb Company 07/17/172D 3D TSV
US9394285 186 Indole and indazole compounds that activate AMPK Pfizer Inc. 07/17/172D 3D TSV
US9394289 44 Inhibitors of c-fms kinase Janssen Pharmaceutica NV 07/17/172D 3D TSV
US9403804 10 Inhibitors of c-fms kinase Janssen Pharmaceutica NV 07/17/172D 3D TSV
US9388165 22 Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinase HANMI PHARM. CO., LTD. 07/17/172D 3D TSV
US9402837 20 Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase Amicus Therapeutics, Inc. 07/17/172D 3D TSV
US9409887 14 Mutant-selective EGFR inhibitors and uses thereof Celgene Avilomics Research, Inc. 07/17/172D 3D TSV
US9388210 17 Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same WASHINGTON UNIVERSITY 07/17/172D 3D TSV
US9394282 406 Pyrazole carboxamides as Janus kinase inhibitors Merck Sharp & Dohme Corp. 07/17/172D 3D TSV
US9394290 90 Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases UNIVERSITAET DES SAARLANDES CAMPUS SAARBRUECKEN 07/17/172D 3D TSV
US9394303 31 Small molecule inhibitors of MCL-1 and uses thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN 07/17/172D 3D TSV
US9393232 171 Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones BeiGene, Ltd. 07/17/172D 3D TSV
US9394263 237 Substituted hetero-azepinones F. HOFFMANN-LA ROCHE AG 07/17/172D 3D TSV
US9394250 56 Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases ONO PHARMACEUTICAL CO., LTD. 07/17/172D 3D TSV
US9402842 12 Synthesis and use of dual tyrosyl-DNA phosphodiesterase I (Tdp1)—topoisomerase I (Top1) inhibitors Purdue Research Foundation 07/17/172D 3D TSV
US9394293 17 TRPV1 antagonists including dihydroxy substituent and uses thereof Purdue Pharma L.P. 07/17/172D 3D TSV
US9394254 6 Antibiotic and anti-parasitic agents that modulate class II fructose 1,6-bisphosphate aldolase The University of Denver and Regis University 07/10/172D 3D TSV
US9403822 5 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases ABBVIE INC. 07/10/172D 3D TSV
US9365589 82 C5, C6 oxacyclic-fused thiazine dioxide compounds as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 07/10/172D 3D TSV
US9402878 2 Depsipeptide and uses thereof NovoBiotic Pharmaceuticals, LLC 07/10/172D 3D TSV
US9388139 97 Derivatives of celeboxib, use thereof and preparation thereof German University; Southern Research Institute 07/10/172D 3D TSV
US9388149 69 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases GALDERMA RESEARCH & DEVELOPMENT 07/10/172D 3D TSV
US9394307 6 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as CCR2 modulators for the treatment of inflammation ChemoCentryx, Inc. 07/10/172D 3D TSV
US9388197 76 Heterocyclic amide derivatives as P2X7 receptor antagonists ACTELION PHARMACEUTICALS LTD. 07/10/172D 3D TSV
US9388198 17 Heterocyclic amide derivatives as P2X7 receptor antagonists ACTELION PHARMACEUTICALS LTD. 07/10/172D 3D TSV
US9394304 18 Imidazopyridine derivatives Hoffmann-La Roche Inc. 07/10/172D 3D TSV
US9365582 24 Macrocyclic inhibitors of hepatitis C virus Janssen Sciences Ireland UC 07/10/172D 3D TSV
US9388176 119 Method of treating conditiions with kinase inhibitors ALLERGAN, INC. 07/10/172D 3D TSV
US9365572 65 PI3K and/or mTOR inhibitor Xuanzhu Pharma Co., Ltd. 07/10/172D 3D TSV
US9403799 14 Pyrimidinyl-pyridazinone derivatives for treating a disease which is influenced by inhibition of met kinase MERCK PATENT GMBH 07/10/172D 3D TSV
US9388199 44 Pyrrolidine derivatives and their use as complement pathway modulators NOVARTIS AG 07/10/172D 3D TSV
US9388189 81 Pyrrolotriazinone derivatives as PI3K inhibitors Almirall, S.A. 07/10/172D 3D TSV
US9388171 28 Serine/threonine kinase inhibitors GENETECH, INC.; ARRAY BIOPHARMA INC. 07/10/172D 3D TSV
US9394276 16 Substituted 1,2,3,4-tetrahydro-2,6-naphthyridines as factor XIa inhibitors Bristol-Myers Squibb Company 07/10/172D 3D TSV
US9388181 15 Substituted 1,2,3,4-tetrahydropyrido[3,4-E] pyrrolo[1,2-A]pyrimidines as kinase Allergan, Inc. 07/10/172D 3D TSV
US9388140 120 Substituted benzimidazoles Bayer Intellectual Property GmbH 07/10/172D 3D TSV
US9388162 146 Substituted morphinans and the use thereof Purdue Pharma L.P. 07/10/172D 3D TSV
US9388136 35 Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof Chroma Therapeutics Ltd 07/10/172D 3D TSV
USRE46024 22 Thyroid hormone analogs Hoffmann-La Roche Inc. 07/10/172D 3D TSV
US9365562 126 1,3 substituted azetidine PDE10 inhibitors Merck Sharp & Dohme Corp. 07/03/172D 3D TSV
US9364459 43 3-(indolyl)- or 3-(azaindolyl)- 4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarcinoma Johannes Gutenberg-Universität Mainz; Universitätsmedizin der Johannes Gutenberg-Universität Mainz 07/03/172D 3D TSV
US9365508 26 Aroyl thiourea derivatives University Court of the University of St Andrews; University Court of the University of Dundee 07/03/172D 3D TSV
US9365534 43 Arylated camphenes, processes for their preparation and uses thereof YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. 07/03/172D 3D TSV
US9365529 68 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics GALDERMA RESEARCH & DEVLOPMENT 07/03/172D 3D TSV
US9359371 77 Bicyclic substituted pyrimidine compounds XUANZHU PHARMA CO., LTD. 07/03/172D 3D TSV
US9365511 26 Biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disorders ARENA PHARMACEUTICALS, INC. 07/03/172D 3D TSV
US9359372 60 Hexahydrodibenzo[a,g]quinolizine compound, preparation method thereof, pharmaceutical composition and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES 07/03/172D 3D TSV
US9359361 20 Immune system modulators JANUS BIOTHERAPEUTICS, INC. 07/03/172D 3D TSV
US9365575 25 Kinase inhibitors Allergan, Inc. 07/03/172D 3D TSV
US9365853 7 Matriptase inhibitors and uses thereof against orthomyxoviridae infections TBA 07/03/172D 3D TSV
US9365502 18 Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors WASHINGTON UNIVERSITY 07/03/172D 3D TSV
US9365539 11 Prolylcarboxypeptidase inhibitors Merck Sharp & Dohme Corp. 07/03/172D 3D TSV
US9365576 279 Pyrrolopyrrolidinone compounds Novartis AG 07/03/172D 3D TSV
US9388137 9 Quaternized amines as sodium channel blockers Purdue Pharma L.P. 07/03/172D 3D TSV
US9394283 2 Salt form of a human histone methyltransferase EZH2 inhibitor Epizyme, Inc.; Eisai R&D Management Co., LTD. 07/03/172D 3D TSV
US9364482 134 Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp. 07/03/172D 3D TSV
US9394281 12 Substituted heteroaryl compounds and methods of use CALITOR SCIENCES, LLC; SUNSHINE LAKE PHARMA CO., LTD. 07/03/172D 3D TSV
US9365546 8 Substituted pyridinone-pyridinyl compounds CONFLUENCE LIFE SCIENCES INC. 07/03/172D 3D TSV
US9359399 71 Synthetic peptide amides Cara Therapeutics, Inc. 07/03/172D 3D TSV
US9365563 228 TRPV1 antagonists including dihydroxy substituent and uses thereof Purdue Pharma L.P. 07/03/172D 3D TSV
US9359338 366 Cyclopropanecarboxamido-substitute aromatic compounds as anti-tumor agents CROWN BIOSCIENCE INC. (Taiwan) 06/27/172D 3D TSV
US9388160 4 Quinazoline derivatives as kinases inhibitors and methods of use thereof Teligene Ltd 06/27/172D 3D TSV
US9388170 7 Substituted aminoquinazolines useful as kinases inhibitors TBA 06/27/172D 3D TSV
US9353084 49 2-amino 3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer's disease H. Lundbeck A/S 06/26/172D 3D TSV
US9359337 12 Acetamide derivatives Hoffmann-La Roche Inc. 06/26/172D 3D TSV
US9359341 11 Aldehyde derivative of substitute oxazolidinones WANBURY LTD. 06/26/172D 3D TSV
US9353089 180 Compositions and methods for the treatment of malaria Saint Louis University; Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences 06/26/172D 3D TSV
US9353101 64 Cyclic amine substituted heterocyclic CETP inhibitors Merck Sharp & Dohme Corp. 06/26/172D 3D TSV
US9359348 11 Cyclopropyl imidazopyridine PDE10 inhibitors Merck Sharp & Dohme Corp. 06/26/172D 3D TSV
US9365558 99 Dihydropyridinone MGAT2 inhibitors Bristol-Myers Squibb Company 06/26/172D 3D TSV
US9359339 19 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use Merck Sharp & Dohme Corp. 06/26/172D 3D TSV
US9353093 63 Indole-1-carboxamides as kinase inhibitors Allergan, Inc. 06/26/172D 3D TSV
US9353116 62 Methods and compositions for kinase inhibition The Regents of the University of California 06/26/172D 3D TSV
US9353102 88 Non-annulated thiophenylamides Hoffmann-La Roche Inc. 06/26/172D 3D TSV
US9353104 130 Substituted pyridizinone derivatives as PDE10 inhibitors Merck Sharp & Dohme Corp. 06/26/172D 3D TSV
US9359345 12 Thiazole derivatives as inhibitors of Bruton's tyrosine kinase HOFFMANN-LA ROCHE INC. 06/26/172D 3D TSV
US9393245 88 Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors vTv Therapeutics LLC 06/26/172D 3D TSV
US9353061 28 3,5,N-trihydroxy-alkanamide and derivatives: method for making same and use thereof ACADEMIA SINICA; NATIONAL TAIWAN UNIVERSITY 06/19/172D 3D TSV
US9346829 31 5-HT3 receptor antagonists Takeda Phamaceutical Company Limited 06/19/172D 3D TSV
US9353081 132 Bicyclic dihydroquinoline-2-one derivatives Hoffmann-La Roche Inc. 06/19/172D 3D TSV
US9353075 66 Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA) The Regents of the University of California; Fondazione Istituto Italiano Di Technologia; Universita Degli Studi Di Parma; Universita Degli Studi Di Urbino “Carlo Bo” 06/19/172D 3D TSV
US9359301 14 Ethynyl derivatives Hoffmann-La Roche Inc. 06/19/172D 3D TSV
US9346814 250 FAP inhibitors Universiteit Antwerp; Fox Chase Cancer Center 06/19/172D 3D TSV
US9346821 66 Heterocyclic carboxylic acid ester derivative AJINOMOTO CO., INC. 06/19/172D 3D TSV
US9353090 331 Heterocyclic carboxylic acids as activators of soluble guanylate cyclase Boehringer Ingelheim International GmbH 06/19/172D 3D TSV
US9351965 152 Indazole derivatives useful as ERK inhibitors Merck Sharp & Dohme Corp. 06/19/172D 3D TSV
US9359293 24 Methods of treatment using modulators of SIRT2 CORNELL UNIVERSITY 06/19/172D 3D TSV
US9346786 123 Pyrrolidine compounds Hoffmann-La Roche Inc. 06/19/172D 3D TSV
US9353066 228 Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors Merck Sharp & Dohme Corp.; Merck Canada Inc. 06/19/172D 3D TSV
US9359330 25 Substituted piperidines as sodium channel blockers Purdue Pharma L.P. 06/19/172D 3D TSV
US9346815 934 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof Genentech, Inc. 06/12/172D 3D TSV
US9345742 42 Aminostatin derivatives for the treatment of arthrosis MERCK PATENT GMBH 06/12/172D 3D TSV
US9346770 29 Compounds having activating effect on subtypes of peroxisome proliferator-activated receptors and its preparation method and uses ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. 06/12/172D 3D TSV
US9353067 3 Heterocyclic compounds and uses thereof in the treatment of sexual disorders ATIR Holding S.A. 06/12/172D 3D TSV
US9353115 11 Immune system modulators JANUS BIOTHERAPEUTICS, INC. 06/12/172D 3D TSV
US9353083 4 Oxazetidine derivatives, process for preparing them and use in human medicine and in cosmetics GALDERMA RESEARCH & DEVELOPMENT 06/12/172D 3D TSV
US9358227 12 Pharmaceutical uses of 6-amino quinazoline or 3-cyano quinoline derivatives Jiangsu Hengrui Medicine Co., Ltd.; Shanghai Hengrui Pharmaceutical Co., Ltd. 06/12/172D 3D TSV
US9346839 11 Phosphonate derivatives and methods of use thereof in the treatment of Alzheimer's disease University of Kansas 06/12/172D 3D TSV
US9351973 15 Pyrazolopyridyl compounds as aldosterone synthase inhibitors Merck Sharp & Dohme Corp. 06/12/172D 3D TSV
US9346794 85 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity Boehringer Ingelheim International GmbH 06/12/172D 3D TSV
US9346795 186 Substituted sulfonamides useful as antiapoptotic Bcl inhibitors Bristol-Myers Squibb Company 06/12/172D 3D TSV
US9353113 13 Tetrahydrocarboline derivative ONO PHARMACEUTICAL CO., LTD. 06/12/172D 3D TSV
US9346827 11 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use Amgen Inc. 06/05/172D 3D TSV
US9346782 60 Alkyl linked quinolinyl modulators of RORγt Janssen Pharmaceutica NV 06/05/172D 3D TSV
US9346818 42 Benzodioxole derivative and preparation method and use thereof Zhejiang Hisun Pharmaceutical Co., Ltd. 06/05/172D 3D TSV
US9345700 53 Compositions and methods useful for treating diseases Eutropics Pharmaceuticals, Inc. 06/05/172D 3D TSV
US9346798 678 Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors AMGEN INC. 06/05/172D 3D TSV
US9346803 44 Indomethacin analogs for the treatment of castrate-resistant prostate cancer Vanderbilt University; The Trustees of the University of Pennsylvania 06/05/172D 3D TSV
US9340574 25 Inhibitors of protein tyrosine phosphatases Indiana University Research and Technology Corporation 06/05/172D 3D TSV
US9340549 193 Oxazolidinone compounds and derivatives thereof AMGEN INC. 06/05/172D 3D TSV
US9346787 28 Piperidine compound or salt thereof TAIHO PHARMACEUTICAL CO., LTD. 06/05/172D 3D TSV
US9339501 54 17a-hydroxylase/C17,20-lyase inhibitors NOVARTIS AG 05/31/172D 3D TSV
US9346797 14 2-amino 6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors H. Lundbeck A/S 05/31/172D 3D TSV
US9340500 154 Aromatic heterocyclic derivative having TRPV4-inhibiting activity SHIONOGI & CO., LTD. 05/31/172D 3D TSV
US9340537 173 Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 NOVATIS AG 05/31/172D 3D TSV
US9334269 337 Carboxamides as inhibitors of voltage-gated sodium channels AMGEN INC. 05/31/172D 3D TSV
US9346793 15 Hydroxylated aminotriazole derivatives as ALX receptor agonists Actelion Pharmaceuticals, LTD. 05/31/172D 3D TSV
US9340517 531 Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor Mimetica PTY LTD 05/31/172D 3D TSV
US9334286 108 Pharmacologically active compounds Cancer Research Technology Limited 05/31/172D 3D TSV
US9340530 84 Preparation and use of bicyclic himbacine derivatives as PAR-1 receptor antagonists Merck Sharp & Dohme Corp. 05/31/172D 3D TSV
US9340507 111 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity Boehringer Ingelheim International GmbH 05/31/172D 3D TSV
US9353062 2 Substituted quinolines as bruton's tyrosine kinases inhibitors HangzhouDeRenYuCheng Biotechnology Ltd 05/31/172D 3D TSV
US9334290 152 Substituted tetrahydrocarbazole and carbazole carboxamide compounds Bristol-Myers Squibb Company 05/31/172D 3D TSV
US9340510 245 Tetrahydroisoquinoline derivatives, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 05/31/172D 3D TSV
US9346822 4 Thienopyrimidine compounds and use thereof Takeda Pharmaceutical Company Limited 05/31/172D 3D TSV
US9340506 38 Acetamide derivatives as glucokinase activators, their process and medicinal applications ADVINUS THERAPEUTICS LIMITED 05/22/172D 3D TSV
US9340573 28 Azaindolines Hoffmann-La Roche Inc. 05/22/172D 3D TSV
US9340555 180 Compounds as tyrosine kinase modulators Allergan, Inc. 05/22/172D 3D TSV
US9345793 20 Compounds for binding to the platelet specific glycoprotein IIB/IIIA and their use for imaging of thrombi PIRAMAL IMAGING SA 05/22/172D 3D TSV
US9334279 129 Hepatitis C virus inhibitors Bristol-Myers Squibb Company 05/22/172D 3D TSV
US9345740 24 IAP antagonists Bristol-Myers Squibb Company 05/22/172D 3D TSV
US9340521 130 Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives GREEN CROSS CORPORATION 05/22/172D 3D TSV
US9340542 20 Propellane-based compounds and the use thereof Purdue Pharma L.P. 05/22/172D 3D TSV
US9340504 6 Pyridine and piperidine derivatives as novel sodium channel blockers Purdue Pharma L.P. 05/22/172D 3D TSV
US9346810 249 Pyrrolopyrimidine compounds and uses thereof HUTCHISON MEDIPHARMA LIMITED 05/22/172D 3D TSV
US9334288 34 Selective β-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents The University of North Carolina at Chapel Hill 05/22/172D 3D TSV
US9345789 13 Specific inhibitors and active site probes for legumain The Board of Trustees of the Leland Stanford Junior University 05/22/172D 3D TSV
US9328099 1336 Cyanomethylpyrazole carboxamides as janus kinase inhibitors Merck Sharp & Dohme Corp. 05/18/172D 3D TSV
US9333195 34 Quinuclidine derivatives and medicinal compositions containing the same ALMIRALL, S.A. 05/18/172D 3D TSV
US9334268 25 4-amino-imidazoquinoline compounds HOFFMAN-LA ROCHE INC. 05/15/172D 3D TSV
US9340534 4 Compounds and methods for treating ocular diseases ALLERGAN, INC. 05/15/172D 3D TSV
US9328106 297 Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use GENENTECH, INC. 05/15/172D 3D TSV
US9339486 15 Heterocyclic modulators of cannabinoid receptors The Cleveland Clinic Foundation 05/15/172D 3D TSV
US9333217 10 Inhibitors of human EZH2, and methods of use thereof Epizyme, Inc. 05/15/172D 3D TSV
US9333205 6 Isoxazolo-quinazolines as modulators of protein kinase activity NERVIANO MEDICAL SCIENCES S.R.L. 05/15/172D 3D TSV
US9333199 13 Methods of treatment of histamine H-4 receptor-related pruritus associated with nerve disorders BRIDGE PHARMA, INC. 05/15/172D 3D TSV
US9340511 7 Process for making isoquinoline compounds FibroGen, Inc. 05/15/172D 3D TSV
US9334271 32 Purine derivatives and their use in the treatment of disease Novarits AG 05/15/172D 3D TSV
US9321790 119 Pyrimidinone derivatives as antimalarial agents Sanofi 05/15/172D 3D TSV
US9334278 38 Pyrrolo[2,3-B]pyrazines as SYK inhibitors Hoffmann-La Roche Inc. 05/15/172D 3D TSV
US9328096 800 Tropomyosin-related kinase inhibitors Pfizer Inc. 05/15/172D 3D TSV
US9328120 34 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders Boehringer Ingelheim International GmbH 05/08/172D 3D TSV
US9321791 46 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions Boehringer Ingelheim International GmbH 05/08/172D 3D TSV
US9326978 16 A3 adenosine receptor allosteric modulators The United States of America, Represented by the Secretary, Dept. of Health and Human Services; Universiteit Leiden 05/08/172D 3D TSV
US9321760 243 Aminopyrimidine derivatives for use as modulators of kinase activity Merck Patent GmbH 05/08/172D 3D TSV
US9333197 9 Apoptosis signal-regulating kinase inhibitor Gilead Sciences, Inc. 05/08/172D 3D TSV
US9321756 823 Azole compounds as PIM inhibitors AMGEN INC. 05/08/172D 3D TSV
US9328124 3 BACE inhibitors Eli Lilly and Company 05/08/172D 3D TSV
US9321773 21 Compounds Respivert, Ltd. 05/08/172D 3D TSV
US9328070 8 Ethynyl derivatives Hoffmann-La Roche Inc. 05/08/172D 3D TSV
US9328118 159 Nitrogen-containing bicyclic aromatic heterocyclic compound Astellas Pharma Inc. 05/08/172D 3D TSV
US9328123 5 Rotenone derivatives and a use thereof Korea Atomic Energy Research Institute 05/08/172D 3D TSV
US9328111 39 Substituted cycloocta[5,6]pyrido[4,3,2-de]phthalazines as PARP inhibitors BeiGene Ltd. 05/08/172D 3D TSV
US9328112 193 Tetracyclic CDK9 kinase inhibitors AbbVie Inc. 05/03/172D 3D TSV
US9315520 135 2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides Pfizer Inc. 05/01/172D 3D TSV
US9321748 59 Aminopyridine derived compounds as LRRK2 inhibitors H. Lundbeck A/S; Vernalis (R&D) Ltd. 05/01/172D 3D TSV
US9321728 33 Beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY; HANDOK PHARMACEUTICALS CO., LTD. 05/01/172D 3D TSV
US9320741 14 Compositions and methods for treating neoplasia, inflammatory disease and other disorders DANA-FARBER CANCER INSTITUTE, INC. 05/01/172D 3D TSV
US9321743 25 Compositions and methods of inhibiting N-acylethanolamine-hydrolyzing acid amidase The Regents of the University of California; Universita Degli Studi Di Parma; Universita Degli Studi Di Urbino “Carlo Bo” 05/01/172D 3D TSV
US9321766 10 Kinase inhibitors Allergan, Inc. 05/01/172D 3D TSV
US9321738 28 N-alkyltriazole compounds as LPAR antagonists HOFFMAN-LA ROCHE INC. 05/01/172D 3D TSV
US9321752 10 Pyrazole derivative GREEN TECH CO., LTD. 05/01/172D 3D TSV
US9321750 5 ROR modulators and their uses INNOV17 LLC 05/01/172D 3D TSV
US9320722 81 Regulators of aldehyde dehydrogenase ALDH3A1 and related therapeutic methods Indiana University Research and Technology Corporation 05/01/172D 3D TSV
US9320734 110 Small molecule inhibitors of the pleckstrin homology domain and methods for using same Board of Regents, The University of Texas System; Arizona Board of Regents on behalf of the University of Arizona 05/01/172D 3D TSV
US20160326143 65 Compounds and uses Astrazeneca Ab 04/27/172D 3D TSV
US9320732 21 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase Incyte Corporation; Incyte Holdings Corporation 04/24/172D 3D TSV
US9315514 32 1,3-dioxanomorphides and 1,3-dioxanocodides Rhodes Technologies 04/24/172D 3D TSV
US9321747 21 Acid addition salt of substituted pyridine compound DAIICHI SANKYO COMPANY, LIMITED; UBE INDUSTRIES, LTD. 04/24/172D 3D TSV
US9315498 174 Arlethynyl derivatives HOFFMAN-LA ROCHE INC. 04/24/172D 3D TSV
US9315500 26 Bicyclic heteroaryl cycloalkyldiamine derivatives NOVARTIS AG 04/24/172D 3D TSV
US9315489 98 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Novartis AG 04/24/172D 3D TSV
US9315499 41 Cytomegalovirus inhibitor compounds Boehringer Ingelheim International GmbH 04/24/172D 3D TSV
US9315519 6 Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitors Bristol-Myers Squibb Company 04/24/172D 3D TSV
US9315518 40 Imidazopyridin-2-one derivatives Merck Sharp & Dohme Corp. 04/24/172D 3D TSV
US9321721 8 Kinase inhibitors Allergan, Inc. 04/24/172D 3D TSV
US9315493 18 Phenylpyridine derivative and drug containing same KOWA COMPANY, LTD. 04/24/172D 3D TSV
US9315491 129 Pyrimidine compounds as mTOR and PI3K inhibitors DEVELOPMENT CENTER FOR BIOTECHNOLOGY; DCB-USA LLC 04/24/172D 3D TSV
US9320737 32 Substituted imidazopyridazines BAYER INTELLECTUAL PROPERTY GMBH 04/24/172D 3D TSV
US9315508 3 Treating diabetes with dipeptidyl peptidase-IV inhibitors Merck sharp & Dohme Corp. 04/24/172D 3D TSV
US9303017 131 2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof Georgetown University; Duke University 04/10/172D 3D TSV
US9303045 162 5-HT3 receptor antagonists Takeda Pharmaceutical Company Limited 04/10/172D 3D TSV
US9303025 407 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases AbbVie Inc. 04/10/172D 3D TSV
US9314468 140 Chemokine receptor modulators Altiris Therapeutics, Inc. 04/10/172D 3D TSV
US9314464 22 Compounds and compositions as protein kinase inhibitors Novartis AG 04/10/172D 3D TSV
US9315463 30 Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities Almirall, S.A. 04/10/172D 3D TSV
US9303015 151 Heteroaryl linked quinolinyl modulators of RORγt JANSSEN PHARMACEUTICA NV 04/10/172D 3D TSV
US9315492 29 Heterocyclic group contained amino-methanol derivative, and salt, synthetic method and use thereof Beijing Foreland Biopharma Co., Ltd. 04/10/172D 3D TSV
US9315438 10 Optically pure benzyl-4-chlorophenyl-C-glucoside derivative XUANZHU PHARMA CO., LTD 04/10/172D 3D TSV
US9303023 145 Pyrazole and imidazole derivatives useful as orexin antagonists ACTELION PHARMACEUTICALS LTD. 04/10/172D 3D TSV
US9303012 304 Pyridine-2-amides useful as CB2 agonists HOFFMAN-LA ROCHE INC. 04/10/172D 3D TSV
US9303035 36 Substituted pyrazino[1′,2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel Novartis AG 04/10/172D 3D TSV
US9284322 30 Nicotinic receptor compounds Research Triangle Institute 04/04/172D 3D TSV
US9296759 188 Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use Amgen Inc. 04/03/172D 3D TSV
US9290488 165 Azetidine-substituted quinoxalines as opioid receptor like-1 modulators Purdue Pharma L.P. 04/03/172D 3D TSV
US9271961 119 Bifunctional AKR1C3 inhibitors/androgen receptor modulators and methods of use thereof The Trustees of the University of Pennsylvania 04/03/172D 3D TSV
US9296741 698 Bromodomain inhibitors AbbVie Inc. 04/03/172D 3D TSV
US9296708 17 Chimeric small molecules for the recruitment of antibodies to cancer cells YALE UNIVERSITY 04/03/172D 3D TSV
US9302996 148 Continuous arycyclic compound MITSUBISHI TANABE PHARMA CORPORATION 04/03/172D 3D TSV
US9278100 149 Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors Pharmacyclics LLC 04/03/172D 3D TSV
US9290476 160 Methylene linked quinolinyl modulators of RORγt JANSSEN PHARMACEUTICA NV 04/03/172D 3D TSV
US9271963 95 Selective inhibitors of human corticosteroid synthases UNIVERSITAT DES SAARLANDES 04/03/172D 3D TSV
US9278925 146 Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one BAYER INTELLECTUAL PROPERTY GMBH 04/03/172D 3D TSV
US9302986 97 Substituted 3-haloallylamine inhibitors of ASSAO and uses thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH 04/03/172D 3D TSV
US9303033 2239 Pyrazolopyrimidines and related heterocycles as CK2 inhibitors SENHWA BIOSCIENCES, INC. 03/30/172D 3D TSV
US9302985 17 Benzyl sulfonamide derivatives as RORc modulators Genentech, Inc. 03/21/172D 3D TSV
US9212182 776 Bicyclic sulfonamide compounds as sodium channel inhibitors Amgen Inc. 03/21/172D 3D TSV
US9296681 36 Cycloalkylmethylamines REVIVA PHARMACEUTICALS, INC. 03/21/172D 3D TSV
US9289400 6 D3 dopamine receptor agonists to treat dyskinesia in parkinson's disease Drexel University; Rutgers, The State University of New Jersey 03/21/172D 3D TSV
US9284333 390 Fused pyrroledicarboxamides and their use as pharmaceuticals Sanofi 03/21/172D 3D TSV
US9249087 156 HDAC inhibitors and therapeutic methods using the same THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS; THE CHILDREN'S HOSPITAL OF PHILADELPHIA 03/21/172D 3D TSV
US9290501 16 Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase Albert Einstein College of Medicine, Inc.; Victoria Link Limited 03/21/172D 3D TSV
US9296757 92 Substituted benzothienopyrimidines BAYER PHARMA AKTIENGESELLSCHAFT 03/21/172D 3D TSV
US9260435 16 Substituted imidazopyrazines as Akt kinase inhibitors BAYER PHARMA AKTIENGESELLSCHAFT 03/21/172D 3D TSV
US9303018 23 Inhibitors of leukotriene production Boehringer Ingelheim International GmbH 03/13/172D 3D TSV
US9302989 1657 NAMPT and rock inhibitors AbbVie Inc. 03/13/172D 3D TSV
US9303019 12 Amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome UNIVERSITE DE STRASBOURG 03/06/172D 3D TSV
US9296745 236 Diacylglycerol acyltransferase 2 inhibitors Pfizer Inc. 03/06/172D 3D TSV
US9296734 722 Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use Amgen Inc. 03/06/172D 3D TSV
US9296736 497 Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer Amgen INC. 03/06/172D 3D TSV
US9296748 113 Pyridinones Boehringer Ingelheim International GmbH 03/06/172D 3D TSV
US9302981 6 Synthesis, methods of using, and compositions of cycloalkylmethylamines REVIVA PHARMACEUTICALS, Inc. 03/06/172D 3D TSV
US9303005 4 Use of dibenzofuranone derivatives to inhibit kinases TBA 03/06/172D 3D TSV
US9296747 30 Piperidylpyrimidine derivatives as modulators of protein kinase inhibitors and of vascular endothelial growth factor receptor 2 Allergan, Inc. 02/28/172D 3D TSV
US9296703 2 Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors University of Utah Research Foundation 02/28/172D 3D TSV
US9296728 26 Therapeutic compounds Regents of the University of Minnesota 02/28/172D 3D TSV
US9284330 29 1,4-dihydro-naphthyridine derivative and pharmaceutical composition and use thereof Jiangsu Simovay Pharmaceutical Co., Ltd. 02/27/172D 3D TSV
US9296693 133 Acyl piperidine inhibitors of soluble epoxide hydrolase The Regents of the University of California 02/27/172D 3D TSV
US9284319 34 Heterocyclyl aminoimidazopyridazines BAYER INTELLECTUAL PROPERTY GMBH 02/27/172D 3D TSV
US9283222 773 Inhibitors of poly(ADP-ribose)polymerase AbbVie Inc. 02/27/172D 3D TSV
US9295672 37 Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof Ambit Biosciences Corporation 02/27/172D 3D TSV
US9278978 83 6-Alkynyl Pyridine Boehringer Ingelheim International GmbH 02/21/172D 3D TSV
US9278976 8 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes Merck Sharp & Dohme Corp. 02/21/172D 3D TSV
US9278981 551 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1 Novartis AG 02/21/172D 3D TSV
US9284302 4 Cyclobutyl benzimidazoles as PDE 10 inhibitors Merck Sharp & Dohme Corp. 02/21/172D 3D TSV
US9278968 106 Imidazopyridine compounds Astellas Pharma Inc. 02/21/172D 3D TSV
US9284284 64 Oxazine derivatives and their use in the treatment of disease NOVARTIS AG 02/21/172D 3D TSV
US9296775 3 Pyrazole compounds ELI LILLY AND COMPANY 02/21/172D 3D TSV
US9284298 8 Pyrazolyl-pyrimidine derivatives as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 02/21/172D 3D TSV
US9283225 2 Pyrido-pyrimidine derivatives Merck Patent GmbH 02/21/172D 3D TSV
US9284299 58 Substituted 1H-indazol-1-ol analogs as inhibitors of beta catenin/Tcf protein-protein interactions University of Utah Research Foundation 02/21/172D 3D TSV
US9284317 29 Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitors Bayer Intellectual Property GmbH 02/21/172D 3D TSV
US9284315 32 Three-ring PI3K and/or mTOR inhibitor ZUANZHU PHARMA CO., LTD. 02/21/172D 3D TSV
US9290517 25 Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives Merck Sharp & Dohme Corp. 02/14/172D 3D TSV
US9278963 124 Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors Acetylon Pharmaceuticals, Inc. 02/14/172D 3D TSV
US9278960 315 Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use Merck Sharp & Dohme Corp. 02/14/172D 3D TSV
US9278093 8 Aldosterone synthase inhibitors Merck Sharp & Dohme Corp.; ElexoPharm GmbH 02/13/172D 3D TSV
US9278953 14 Antagonists of prostaglandin EP3 receptor Pfizer Inc. 02/13/172D 3D TSV
US9278930 32 Methods for increasing the stabilization of hypoxia inducible factor-α AERPIO THERAPEUTICS, INC. 02/13/172D 3D TSV
US9278944 131 Nitrogen-containing saturated heterocyclic compound MITSUBISHI TANABE PHARMA CORPORATION; SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. 02/13/172D 3D TSV
US8772490 5 Optically active diazabicyclooctane derivatives and process for preparing the same Meiji Seika Pharma Co., Ltd. 02/13/172D 3D TSV
US9278954 172 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 02/13/172D 3D TSV
US9278914 5 SARMs and method of use thereof University of Tennessee Research Foundation 02/13/172D 3D TSV
US9278918 32 Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors Hoffmann-La Roche Inc. 02/13/172D 3D TSV
US9290482 8 Amino-substituted imidazopyridazines BAYER PHARMA AKTIENGESELLSCHAFT 02/06/172D 3D TSV
US9290490 33 Aminopyrimidines as Syk inhibitors Merck Sharp & Dohme Corp. 02/06/172D 3D TSV
US9290507 137 B-RAF kinase inhibitors Boehringer Ingelheim International GmbH 02/06/172D 3D TSV
US9290481 13 Monocyclic heteroaryl cycloalkyldiamine derivatives NOVARTIS AG 02/06/172D 3D TSV
US9290485 183 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides NOVARTIS AG 02/06/172D 3D TSV
US9290487 74 Pharmaceutical composition for treating diabetes AJINOMOTO CO., INC. 02/06/172D 3D TSV
US9290459 353 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity Boehringer Ingelheim International GmbH 02/06/172D 3D TSV
US9290457 215 Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity Boehringer Ingelheim International GmbH 02/06/172D 3D TSV
US9290505 22 Substituted imidazo[1,2-a]pyrazines as Syk inhibitors Gilead Sciences, Inc. 02/06/172D 3D TSV
US9247759 464 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof Senomyx, Inc. 02/02/172D 3D TSV
US9290467 51 Cyclic amides HOFFMANN—LA ROCHE INC. 01/30/172D 3D TSV
US9273046 116 Fused tricyclic compounds as Raf kinase inhibitors BeiGene, LTD. 01/30/172D 3D TSV
US9290477 7 Inhibitors of β-secretase Vitae Pharmaceuticals, Inc. 01/30/172D 3D TSV
US9290456 68 Pyridazinone compounds and their use as DAAO inhibitors Takeda Pharmaceutical Company Limited 01/30/172D 3D TSV
US9290451 758 Pyridine derivatives as agonists of the CB2 receptor Hoffmann-La Roche Inc. 01/30/172D 3D TSV
US9290463 5 Radiolabeled compounds and uses thereof The Trustees of Columbia University in the City of New York 01/30/172D 3D TSV
US9290454 27 Substituted isoquinolines as CRTH2 receptor modulators Merck Sharp & Dohme Corp. 01/30/172D 3D TSV
US9273053 82 Sulfur-containing heterocyclic derivative having Beta secretase inhibitory activity Shionogi & Co., Ltd. 01/30/172D 3D TSV
US9273043 82 TRPV1 antagonists including dihydroxy substituent and uses thereof Purdue Pharma L.P.; Shionogi & Co., Ltd. 01/30/172D 3D TSV
US9249124 141 Aurora kinase inhibitors and methods of making and using thereof H. Lee Moffitt Cancer Center and Research Institute, Inc. 01/27/172D 3D TSV
US9273042 9 5-amino[1,4]thiazines as BACE 1 inhibitors HOFFMANN-LA ROCHE INC. 01/25/172D 3D TSV
US9273014 82 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof Bristol-Myers Squibb Company 01/24/172D 3D TSV
US9266877 359 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases ABBVIE INC. 01/23/172D 3D TSV
US9271969 134 Compounds as inhibitors of diacylglycerol O-acyltransferase type 1 enzyme KAINOS MEDICINE, INC. 01/23/172D 3D TSV
US9273021 6 Dibenzofuran derivatives as inhibitors of fructose 1,6-bisphosphatase and methods of use thereof TRUSTEES OF BOSTON COLLEGE 01/23/172D 3D TSV
US9273052 5 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof Jiangsu Hansoh Pharmaceutical Co., Ltd. 01/23/172D 3D TSV
US9273029 119 Pyridine-and pyrazine derivatives Merck Patent GmbH 01/23/172D 3D TSV
US9266890 24 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders Dana-Farber Cancer Institute, Inc. 01/23/172D 3D TSV
US9271981 7 Pyrrolo[2,3-D]pyrimidine compounds Zoetis Services LLC 01/23/172D 3D TSV
US9266883 144 Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors Novartis AG 01/23/172D 3D TSV
US9266891 61 Substituted [1,2,4]triazolo[4,3-A]pyrazines that are BRD4 inhibitors Boehringer Ingelheim International GmbH 01/23/172D 3D TSV
US9273011 14 Substituted pyridazines for the treatment of pain Inhibitaxin Limited 01/23/172D 3D TSV
US9273033 142 Substituted pyridone derivatives as PDE10 inhibitors Merck Sharp & Dohme Corp. 01/23/172D 3D TSV
US9243038 35 Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof President and Fellows of Harvard College 01/18/172D 3D TSV
US9233167 124 Oligomer-opioid agonist conjugates Nektar Therapeutics 01/18/172D 3D TSV
US9233947 11 Sulfamides as TRPM8 modulators Janssen Pharmaceutica, NV 01/18/172D 3D TSV
US9266876 244 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives Actelion Pharmaceuticals Ltd. 01/17/172D 3D TSV
US9266870 96 Heteroaromatic methyl cyclic amine derivative TAISHO PHARMACEUTICAL CO., LTD 01/17/172D 3D TSV
US9266878 656 Phosphatidylinositol 3-kinase inhibitors Gilead Calistoga LLC 01/17/172D 3D TSV
US9266880 8 Substituted azaindazole compounds Bristol-Myers Squibb Company 01/17/172D 3D TSV
US9266869 118 Substituted dialkyl(oxido)-lambda4-sulfanylidene nicotinamide derivatives as kinase inhibitors Allergan, Inc. 01/17/172D 3D TSV
US9266895 33 Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors Principia Biopharma Inc. 01/17/172D 3D TSV
US9266881 22 Triazolopyridinone PDE10 inhibitors Merck Sharp & Dohme Corp. 01/17/172D 3D TSV
US9266835 362 Quinoline derivatives useful as CB-1 inverse agonists Janssen Pharmaceutica NV 01/16/172D 3D TSV
US9265773 422 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp.; MSD Italia S.R.L. 01/16/172D 3D TSV
US9233921 34 Potent poxvirus inhibitor THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 01/14/172D 3D TSV
US9266848 37 4-alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide compounds as selective TACE-inhibitors for the treatment of inflammatory diseases GALDERMA RESEARCH & DEVELOPMENT 01/09/172D 3D TSV
US9260455 15 Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 01/09/172D 3D TSV
US9265734 416 Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors BIOMARIN PHARMACEUTICAL INC. 01/09/172D 3D TSV
US9266832 90 Compounds for the treatment of neurodegenerative diseases Katholieke Universiteit Levun; K. U. Leuven R&D reMYND 01/09/172D 3D TSV
US9260439 575 Dihydropyrrolopyrimidine derivatives PFIZER INC. 01/09/172D 3D TSV
US9260440 123 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors BeiGene, Ltd. 01/09/172D 3D TSV
US9266828 5 Inhibitors of Furin and other pro-protein convertases SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 01/09/172D 3D TSV
US9266853 8 Orally available viridiofungin derivative possessing anti-HCV activity Chugai Seiyaku Kabushiki Kaisha 01/09/172D 3D TSV
US9260450 18 Therapeutic pyrazolyl thienopyridines THESAN PHARMACEUTICALS, INC. 01/09/172D 3D TSV
US9266839 2 Trifluoromethyl pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Lycera Corporation 01/09/172D 3D TSV
US9233965 111 3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 delta SANOFI 01/07/172D 3D TSV
US9249163 241 PDE10a inhibitors for the treatment of type II diabetes JANSSEN PHARMACEUTICA NV. 12/31/162D 3D TSV
US9492405 97 Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas The United States of America, as represented by the Secretary, Department of Health and Human Services; SRI International 12/31/162D 3D TSV
US9260415 17 Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality Genentech, Inc. 12/28/162D 3D TSV
US9260413 5 Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders Merck Sharp & Dohme Corp. 12/28/162D 3D TSV
US9259422 35 Orvinol and thevinol derivatives useful in the treatment of depression The University of Bath 12/28/162D 3D TSV
US9260410 8 P38 MAP kinase inhibitors Respivert Ltd. 12/28/162D 3D TSV
US9260425 412 Pyrazolo[3,4-c]pyridine compounds and methods of use Genetech, Inc. 12/28/162D 3D TSV
US9259470 42 Serine/threonine kinase inhibitors Array BioPharma Inc.; Genentech, Inc. 12/28/162D 3D TSV
US9260446 5 Synthetic methods for spiro-oxindole compounds Xenon Pharmaceuticals Inc. 12/28/162D 3D TSV
US9260448 11 Thienopyrimidinone derivatives as mGluR1 antagonists KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 12/28/162D 3D TSV
US9253997 33 Alkylamine derivative AJINOMOTO CO., INC. 12/20/162D 3D TSV
US9255091 15 Benzothiazole-based pyridinium compounds The University of Montana 12/20/162D 3D TSV
US9255107 8 Heteroaryl alkyne compound and use thereof NANJING SANHOME PHARMACEUTICAL CO., LTD. 12/20/162D 3D TSV
US9255090 449 Heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators ACTELION PHARMACEUTICALS LTD. 12/20/162D 3D TSV
US9255110 229 Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators ROCHE PALO ALTO LLC; HOFFMANN-LA ROCHE INC. 12/20/162D 3D TSV
US9255096 26 Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors Allergan, Inc. 12/20/162D 3D TSV
US9255106 46 Substituted [1,2,4]triazolo[4,3-a]pyrazines as PARP-1 inhibitors Shanghai Institute of Materia Medica, Chinese Academy of Sciences 12/20/162D 3D TSV
US9255103 59 Substituted pyrazolo[1,5-a]pyrazines as mGluR5 receptor modulators Vanderbilt University 12/20/162D 3D TSV
US9255098 6 Xanthine derivative Chengdu Easton Pharmaceutical Co., Ltd. 12/20/162D 3D TSV
US9260417 14 Therapeutic methods and compositions involving allosteric kinase inhibition AMITECH THERAPEUTIC SOLUTIONS, INC. 12/15/162D 3D TSV
US9249085 61 Aniline derivatives, their preparation and their therapeutic application FOVEA PHARMACEUTICALS 12/12/162D 3D TSV
US9249151 126 Bis-amido pyridines Boehringer Ingelheim International GmbH 12/12/162D 3D TSV
US9248140 66 Chemical compounds AstraZeneca AB 12/12/162D 3D TSV
US9249139 9 Indolizinone based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof Council of Scientific & Industrial Research 12/12/162D 3D TSV
US9249125 371 Pyrazole derivatives as p38 MAP inhibitors RESPIVERT LIMITED; TOPIVERT PHARMA LIMITED 12/12/162D 3D TSV
US9249123 8 Pyridinones/pyrazinones, method of making, and method of use thereof Genentech, Inc.; Gilead Connecticut, Inc. 12/12/162D 3D TSV
US9249096 30 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors Bristol-Myers Squibb Company 12/12/162D 3D TSV
US9243020 20 Selective glycosidase inhibitors and uses thereof Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. 12/12/162D 3D TSV
US9255087 12 Substituted indazole derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 12/12/162D 3D TSV
US9249114 74 Thiazole derivatives Merck Patent GmbH 12/12/162D 3D TSV
US9227979 64 Fluorescent antagonists of the A3 adenosine receptor The United States of America, as represented by The Secretary, Department of Health and Human Services; Universita Degli Studi Di Trieste; Universita Degli Studi Di Padova 12/08/162D 3D TSV
US9260454 41 Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals SANOFI 12/08/162D 3D TSV
US9242977 42 Trk-inhibiting compound ONO PHARMACEUTICAL CO., LTD. 12/06/162D 3D TSV
US9242988 7 2′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp. 12/05/162D 3D TSV
US9242996 573 Aminoheteroaryl benzamides as kinase inhibitors Novartis AG 12/05/162D 3D TSV
US9242973 532 Chromane compounds COMENTIS, INC. 12/05/162D 3D TSV
US9242998 118 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C Merck Sharp & Dohme Corp. 12/05/162D 3D TSV
US9243002 192 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C Merck Sharp & Dohme Corp. 12/05/162D 3D TSV
US9221809 356 Aminopyrimidinones as interleukin receptor-associated kinase inhibitors MERCK SHARP & DOHME CORP. 11/29/162D 3D TSV
US9242943 66 1,4 oxazines as BACE1 and/or BACE2 inhibitors SIENA BIOTECH S.P.A.; HOFFMANN-LA ROCHE INC. 11/28/162D 3D TSV
US9242969 416 Biaryl amide compounds as kinase inhibitors Novartis AG 11/28/162D 3D TSV
US9238625 33 Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives REVIVA PHARMACEUTICALS, INC. 11/28/162D 3D TSV
US9242981 44 Fused pyrazole derivatives as novel ERK inhibitors Merck Sharp & Dohme Corp. 11/28/162D 3D TSV
US9242975 27 Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors Bristol-Myers Squibb Company 11/28/162D 3D TSV
US9242995 3 Isoxazolopyridine orexin receptor antagonists MERCK SHARP & DOHME CORP. 11/28/162D 3D TSV
US9242970 930 Lactam derivatives useful as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD. 11/28/162D 3D TSV
US9242960 4 P38MAP kinase inhibitors Respivert, Ltd. 11/28/162D 3D TSV
US9242982 7 Pyridopyrimidine based derivatives as potential phosphodiesterase 3 (PDE3) inhibitors and a process for the preparation thereof COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH 11/28/162D 3D TSV
US9242957 72 Thiophene-2-carboximidamide based selective neuronal nitric oxide inhibitors Northwestern University 11/28/162D 3D TSV
US9238651 72 1-H-pyrrolo[2,3-b]pyridine derivatives MERCK PATENT GMBH 11/21/162D 3D TSV
US9238626 42 Beta-amyloid-directed multitarget compounds for the treatment of alzheimer's disease UNIVERSITAT DE BARCELONA; PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE 11/21/162D 3D TSV
US9233979 458 Compounds that are ERK inhibitors Merck Sharp & Dohme Corp. 11/21/162D 3D TSV
US9238629 88 Heteroaryl compounds and uses thereof Celgene Avilomics Research, Inc. 11/21/162D 3D TSV
US9241942 494 IRE-1α inhibitors MannKind Corporation 11/21/162D 3D TSV
US9238619 76 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG; AbbVie Inc. 11/21/162D 3D TSV
US9233983 152 Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof ADVINUS THERAPEUTICS LIMITED 11/21/162D 3D TSV
US9233981 33 Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 11/21/162D 3D TSV
US9238658 49 Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors Janssen Pharmaceutica NV 11/21/162D 3D TSV
US9238644 143 VEGFR3 inhibitors CANCER THERAPEUTICS CRC PTY LIMITED 11/21/162D 3D TSV
US9187424 434 Aryl dihydropyridinones and piperidinone MGAT2 inhibitors Bristol-Myers Squibb Company 11/15/162D 3D TSV
US9227969 101 Compounds and compositions as inhibitors of MEK NOVARTIS AG 11/14/162D 3D TSV
US9233108 30 Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities ALMIRALL, S.A. 11/14/162D 3D TSV
US9233953 161 Derivatives of 4-(piperazinylcarbonyl)thiane-1, 1-dione which inhibit GlyT1 Boehringer Ingelheim International GmbH 11/14/162D 3D TSV
US9226927 15 Gamma secretase inhibitors MERCK SHARP & DOHME CORP. 11/14/162D 3D TSV
US9233086 100 Inhibition of WDR5 interaction with its binding partners THE REGENTS OF THE UNIVERSITY OF MICHIGAN 11/14/162D 3D TSV
US9233968 97 Kinase inhibitors Allergan, Inc. 11/14/162D 3D TSV
US9227975 60 Method of treatment using substituted imidazo[1,2B]pyridazine compounds Array BioPharma, Inc. 11/14/162D 3D TSV
US9227977 14 Phosphoinositide 3-kinase inhibitors Respivert Ltd. 11/14/162D 3D TSV
US9227973 16 Pyridine CGRP receptor antagonists Merck Sharp & Dohme Corp. 11/14/162D 3D TSV
US9233111 72 Pyrrolo pyrimidine derivatives NOVARTIS AG 11/14/162D 3D TSV
US9227956 98 Substituted amide compounds Pfizer Inc. 11/14/162D 3D TSV
US9233946 59 Sulfonamide compounds KANCERA AB 11/14/162D 3D TSV
US9227970 43 Triazolopyridine compounds Hoffmann-La Roche, Inc. 11/14/162D 3D TSV
US9227982 56 4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrminidinyl compounds for use as tankyrase inhibitors NOVARTIS AG 11/08/162D 3D TSV
US9227930 16 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG 11/08/162D 3D TSV
US9234000 417 Benzylamine derivatives as inhibitors of plasma kallikrein Kalvista Pharmaceuticals Limited 11/08/162D 3D TSV
US9221831 451 Buprenorphine analogs Purdue Pharma, L.P. 11/08/162D 3D TSV
US9226922 476 Compounds that are ERK inhibitors Merck Sharp & Dohme Corp. 11/08/162D 3D TSV
US9227959 8 Ethynyl derivatives Hoffman-La Roche Inc. 11/08/162D 3D TSV
US9227949 188 Heteroarylcarboxylic acid ester derivative AJINOMOTO CO., INC. 11/08/162D 3D TSV
US9221808 178 Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of use H. Lee Moffitt Cancer Center and Research Institute, Inc. 11/08/162D 3D TSV
US9226923 19 Spirocyclic molecules as protein kinase inhibitors Nanjing Allgen Pharma Co. Ltd. 11/08/162D 3D TSV
US9216998 56 Tricyclic indole derivatives useful endothelial lipase inhibitors Janssen Pharmaceutica NV 11/08/162D 3D TSV
US9217012 22 Inhibitors of protein tyrosine phosphatases Indiana University Research and Technology Corporation 11/02/162D 3D TSV
US9221802 10 Arylethynyl derivatives Hoffman-La Roche Inc. 10/31/162D 3D TSV
US9221839 30 C5-C6 oxacyclic-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 10/31/162D 3D TSV
US9221832 152 Heterocyclic amide derivatives as P2X7 receptor antagonists ACTELION PHARMACEUTICALS LTD. 10/31/162D 3D TSV
US9221824 5 Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors Incyte Holdings Corporation; Incyte Corporation 10/31/162D 3D TSV
US9221797 93 Inhibitors of c-fms kinase Janssen Pharmaceutica NV 10/31/162D 3D TSV
US9221791 18 Metalloenzyme inhibitor compounds Viamet Pharmaceuticals, Inc. 10/31/162D 3D TSV
US9221828 21 N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)phenyl]sulfonamides as pharmaceuticals SANOFI 10/31/162D 3D TSV
US9221796 174 Selective NR2B antagonists Bristol-Myers Squibb Company 10/31/162D 3D TSV
US9216999 1840 Substituted pyrrolo[2,3-h][1,6]naphthyridines and compositions thereof as JAK inhibitors Nissan Chemical Industries, Ltd. 10/31/162D 3D TSV
US9216984 12 3-[4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane—or heptane-nitrile as JAK inhibitors Incyte Corporation; Incyte Holdings Corporation 10/24/162D 3D TSV
US9216985 41 3-aryl-2-((arylamino)methyl)quinazolin-4-(3H)-ones SciFluor Life Sciences, Inc. 10/24/162D 3D TSV
US9221790 16 Benzamide derivatives Dong-A Pharm. Co., Ltd. 10/24/162D 3D TSV
US9216988 210 Benzyl sulfonamide derivatives as RORc modulators Genentech, Inc. 10/24/162D 3D TSV
US9216968 239 Heterocyclic derivative and pharmaceutical drug NIPPON SHINYAKU CO., LTD. 10/24/162D 3D TSV
US9221795 143 Phosphatidylinositol 3-kinase inhibitors Gilead Sciences, Inc. 10/24/162D 3D TSV
US9216981 88 Purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against Raf kinase, containing same as active ingredient Medpacto, Inc. 10/24/162D 3D TSV
US9216986 52 Quinoline derivatives as PDE10A enzyme inhibitors H. Lundbeck A/S 10/24/162D 3D TSV
US9221767 26 Substituted phthalazinones as rock inhibitors Bristol-Myers Squibb Company 10/24/162D 3D TSV
US9216962 216 Thiazole compounds, methods for preparation and use thereof Shanghai Puyi Chemical Co., Ltd. 10/24/162D 3D TSV
US9216997 21 Tri-heterocyclic derivatives, preparation process and uses thereof Shanghai De Novo Pharmatech Co Ltd. 10/24/162D 3D TSV
US9216972 69 Tricyclic heterocyclic compounds Bristol-Myers Squibb Company 10/24/162D 3D TSV
US9090621 104 Tyrosine kinase inhibitors Principia Biopharma Inc. 10/19/162D 3D TSV
US9212206 8 4-Fluoro-Thio-containing inhibitors of APP2, compositions thereof and method of use TBA 10/18/162D 3D TSV
US9216182 192 Carbamate/urea derivatives containing piperidin and piperazin rings as H3 receptor inhibitors Novartis AG 10/18/162D 3D TSV
US9206164 111 Pyrazole compounds as CRTH2 antagonists Boehringer Ingelheim International GmbH 10/18/162D 3D TSV
US9212144 43 2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition Northwestern University 10/17/162D 3D TSV
US9212184 4 6-thio-substituted imidazo[1,2-a]pyrazines as Mps-1 inhibitors BAYER INTELLECTUAL PROPERTY GMBH 10/17/162D 3D TSV
US9212192 59 Bicyclic carboxamide inhibitors of kinases AbbVie Inc. 10/17/162D 3D TSV
US9212186 25 Bicyclic pyrazole LRRK2 small molecule inhibitors Genentech, Inc. 10/17/162D 3D TSV
US9212147 64 Dihydroxy aromatic heterocyclic compound Takeda Pharmaceutical Company Limited 10/17/162D 3D TSV
US9212171 46 Ethynyl compounds HOFFMANN-LA ROCHE INC. 10/17/162D 3D TSV
US9212196 105 Hypophosphorous acid derivatives having antihyperalgic activity and biological applications thereof UNIVERSITE PARIS DESCARTES; UNIVERSITE D'AUVERGNE 10/17/162D 3D TSV
US9212187 13 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation OTSUKA PHARMACEUTICAL CO., LTD. 10/17/162D 3D TSV
US9212173 37 Pyrazole aminopyrimidine derivatives as LRRK2 modulators Genentech, Inc. 10/17/162D 3D TSV
US9212178 35 Substituted pyrimidine compounds and their use as SYK inhibitors Genosco; Oscotec, Inc. 10/17/162D 3D TSV
US9212145 3 Urea derivatives and uses thereof Kala Pharmaceuticals, Inc. 10/17/162D 3D TSV
US9212140 12 (5s,8s)-3-(4′-chlor-3′-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5] dec-3-en-2-one (compound A) for treatment Bayer Intellectual Property GmbH 10/11/162D 3D TSV
US9212139 88 Aryl substituted indoles and their use as blockers of sodium channels Purdue Pharma, L.P. 10/11/162D 3D TSV
US9212165 28 Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same H. Lundbeck A/S 10/11/162D 3D TSV
US9206201 4 Boronic acid bearing liphagane compounds as inhibitors of P13K-α and/or β Counsel of Scientific & Industrial Research 10/11/162D 3D TSV
US9212130 181 Heterocyclic derivative and pharmaceutical composition comprising the same SHIONOGI & CO., LTD. 10/11/162D 3D TSV
US9206199 217 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 10/11/162D 3D TSV
US9206232 203 Organic compounds and their uses Novartis AG 10/11/162D 3D TSV
US9206188 228 Substituted pyrrolo[2,3-b]pyridines as ITK and JAK inhibitors ARRIEN PHARMACEUTICALS LLC 10/11/162D 3D TSV
US9211296 35 Therapeutic compounds for blocking DNA synthesis of POX viruses The Trustees of the University of Pennsylvania 10/11/162D 3D TSV
US9206173 137 Heterocyclic compounds for the treatment of stress-related conditions OTSUKA PHARMACEUTICAL CO., LTD. 10/10/162D 3D TSV
US9216974 16 Phenoxazine derivatives and methods of use thereof WASHINGTON UNIVERSITY 10/04/162D 3D TSV
US9206129 53 Agent for treatment of eye diseases Daito Chemix Corporation; Kyoto University 10/03/162D 3D TSV
US9206139 65 Aggrecanase inhibitors Eli Lilly and Company 10/03/162D 3D TSV
US9206184 219 Disubstituted benzothienyl-pyrrolotriazines and uses thereof BAYER INTELLECTUAL PROPERTY GmbH 10/03/162D 3D TSV
US9212153 549 Inhibitors of beta-secretase Vitae Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH 10/03/162D 3D TSV
US9206198 113 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 10/03/162D 3D TSV
US9206167 122 Piperazine-substituted benzothiophenes for treatment of mental disorders OTSUKA PHARMACEUTICAL CO., LTD. 10/03/162D 3D TSV
US9206162 53 Triazole compounds that modulate Hsp90 activity Synta Pharmaceuticals Corp. 10/03/162D 3D TSV
US9205085 73 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction Emory University 10/03/162D 3D TSV
US9200020 75 6-oxopurine phosphoribosyltransferase inhibitors THE UNIVERSITY OF QUEENSLAND; INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY ASCR, V.V.I. 09/27/162D 3D TSV
US9199981 176 Compounds and compositions as C-kit kinase inhibitors NOVARTIS AG 09/27/162D 3D TSV
US9200268 5 Compounds and methods for purification of serine proteases Portola Pharmaceuticals, Inc. 09/27/162D 3D TSV
US9199976 17 Haematopoietic-prostaglandin D2 synthase inhibitors The University of Queensland 09/27/162D 3D TSV
US9205078 4 N-methyl-2-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]-benzamide for the treatment of chronic myelogenous leukemia PFIZER INC. 09/27/162D 3D TSV
US9200006 26 Protease inhibitors MEDIVIR AB 09/27/162D 3D TSV
US9199997 3 Purinone derivative hydrochloride ONO PHARMACEUTICAL CO., LTD. 09/27/162D 3D TSV
US9200016 173 Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) Allergan, Inc.; Exonhit Therapeutics, SA 09/27/162D 3D TSV
US9199999 76 Substituted imidazopyrazines Bayer Intellectual Property GmbH 09/27/162D 3D TSV
US9200001 119 Triazolyl PDE10 inhibitors Merck Sharp & Dohme Corp. 09/27/162D 3D TSV
US9199947 140 Biaryl-propionic acid derivatives and their use as pharmaceuticals Sanofi 09/20/162D 3D TSV
US9199927 112 Guanidinobenzoic acid compound Astellas Pharma Inc. 09/20/162D 3D TSV
US9199944 157 N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancer KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY 09/20/162D 3D TSV
US9199949 11 Selective glycosidase inhibitors and uses thereof Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. 09/20/162D 3D TSV
US9193689 18 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) 09/19/162D 3D TSV
US9187487 46 Azaindole derivatives as tyrosine kinase inhibitors PRINCIPIA BIOPHARMA, INC. 09/19/162D 3D TSV
US9192603 67 Heterocyclic sulfone mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction Vanderbilt University 09/19/162D 3D TSV
US9193697 39 Oxazole derivatives useful as modulators of FAAH MERCK SHARP & DOHME CORP. 09/19/162D 3D TSV
US9193736 311 PDE 10a inhibitors for the treatment of type II diabetes Janssen Pharmaceutica, NV 09/19/162D 3D TSV
US9193762 57 Selective inhibitors of prolylcarboxypeptidase UNIVERSITY OF MISSISSIPPI 09/19/162D 3D TSV
US9193726 73 Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders Pfizer Inc. 09/19/162D 3D TSV
US9187470 12 Anti-mucus drugs and uses therefor Washington University 09/12/162D 3D TSV
US9187477 16 Azabenzimidazole derivatives Boehringer Ingelheim International GmbH 09/12/162D 3D TSV
US9187486 205 Bicyclic pyridazine compounds as Pim inhibitors AMGEN INC. 09/12/162D 3D TSV
US9187466 60 Bisaryl-bonded aryltriazolones and use thereof Bayer Intellectual Property GmbH 09/12/162D 3D TSV
US9187469 20 Morpholinylbenzotriazines for use in cancer therapy Merck Patent GmbH 09/12/162D 3D TSV
US9187480 48 Peripherally restricted diphenyl purine derivatives Research Triangle Institute 09/12/162D 3D TSV
US9187459 10 Quinazoline-7-ether compounds and methods of use NewGen Therapeutics, Inc. 09/12/162D 3D TSV
US9187474 8 Raf inhibitor compounds Deciphera Pharmaceuticals, LLC; Eli Lilly and Company 09/12/162D 3D TSV
US9187437 45 Substituted oxadiazole compounds BRISTOL-MYERS SQUIBB COMPANY 09/12/162D 3D TSV
US9187450 56 Substituted pyridine compound Daiichi Sankyo Company, Limited 09/12/162D 3D TSV
US9187462 122 Substituted quinazolines as serine/threonine kinase inhibitors Array BioPharma Inc.; Genentech, Inc. 09/12/162D 3D TSV
US9187441 88 p53-Mdm2 antagonists University of Pittsburgh—Of the Commonwealth System of Higher Education 09/12/162D 3D TSV
US9187406 25 Curcumin analogues as zinc chelators and their uses The Research Foundation of State University of New York; Chem-Master International, Inc. 09/06/162D 3D TSV
US9182402 47 Hepsin inhibitors Fred Hutchinson Cancer Research Center 09/06/162D 3D TSV
US9181263 149 Inhibitors of bruton's tyrosine kinase PHARMACYCLICS LLC 09/06/162D 3D TSV
US9187413 6 Peripherally restricted FAAH inhibitors The Regents of the University of California; Universita Degli Studi Di Parma; Universita Degli Studi Di Urbino 09/06/162D 3D TSV
US9187429 211 Phenyl-tetrahydroisoquinoline derivatives HOFFMANN-LA ROCHE INC. 09/06/162D 3D TSV
US9187430 9 Poly (ADP-ribose) polymerase inhibitor CHENGDU DI'AO PHARMACEUTICAL GROUP CO., LTD. 09/06/162D 3D TSV
US9186318 31 Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof Beijing Konruns Pharmaceutical Co., Ltd 09/06/162D 3D TSV
US9187428 150 Substituted dicyanopyridines and use thereof Bayer Intellectual Property GmbH 09/06/162D 3D TSV
US9187397 23 Therapeutic curcumin derivatives STC.UNM 09/06/162D 3D TSV
US9186360 490 Treatment of respiratory disorders using TRPA1 antagonists GLENMARK PHARMACEUTICALS S.A. 09/06/162D 3D TSV
US9181266 321 2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors NOVARTIS AG 08/29/162D 3D TSV
US9181236 290 2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use Merck Sharp & Dohme Corp. 08/29/162D 3D TSV
US9181253 52 Adenosine receptor agonists, partial agonists, and antagonists The United States of America, as represented by the Secretary, Department of Health and Human Services 08/29/162D 3D TSV
US9181272 300 Aldosterone synthase inhibitors Boehringer Ingelheim International GmbH 08/29/162D 3D TSV
US9181279 16 Cyclic amine derivatives as EP4 receptor antagonists ROTTAPHARM BIOTECH S.R.L. 08/29/162D 3D TSV
US9181233 28 Inhibitors of glutaminyl cyclase PROBIODRUG AG 08/29/162D 3D TSV
US9181275 4 Mercaptoamidine derivatives and methods of use AbbVie Inc. 08/29/162D 3D TSV
US9181258 130 Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 08/29/162D 3D TSV
US9181249 142 Substituted pyrido[3,4-b]pyrazines as GPR6 modulators Takeda Pharmaceutical Company Limited 08/29/162D 3D TSV
US9181261 10 TrkA kinase inhibitors, compositions and methods thereof Merck Sharp & Dohme Corp. 08/29/162D 3D TSV
US9181181 77 2-substituted-3-phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease Albireo AB 08/15/162D 3D TSV
US9180122 35 5- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain Takeda Pharmaceutical Company Limited 08/15/162D 3D TSV
US9181219 48 Compounds of modulating TRPV3 function HYDRA BIOSCIENCES, INC. 08/15/162D 3D TSV
US9180116 72 Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions Cayman Chemical Company, Inc. 08/15/162D 3D TSV
US9175357 23 Fragment ligated inhibitors selective for the polo box domain of PLK1 UNIVERSITY OF SOUTH CAROLINA 08/15/162D 3D TSV
US9181185 25 Heteroaryl compounds as sodium channel blockers Purdue Pharma L.P. 08/15/162D 3D TSV
US9181184 18 Method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives Amicus Therapeutics, Inc. 08/15/162D 3D TSV
US9181230 110 Morpholine compounds and uses thereof Hoffmann-La Roche Inc. 08/15/162D 3D TSV
US9180183 18 Phospholipid drug analogs Telormedix SA 08/15/162D 3D TSV
US9181182 40 S1P receptors modulators Akaal Pharma PTY LTD 08/15/162D 3D TSV
US9180120 38 Substituted N-phenethyltriazoloneacetamides and use thereof Bayer Intellectual Property GmbH 08/15/162D 3D TSV
US9181187 12 Therapeutic agent for urinary excretion disorder ONO PHARMACEUTICAL CO., LTD. 08/15/162D 3D TSV
US9180192 46 mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction Vanderbilt University 08/15/162D 3D TSV
US9174997 29 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof Bayer Intellectual Property GmbH 08/08/162D 3D TSV
US9174982 360 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases ABBVIE INC.; GENENTECH, INC.; THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH 08/08/162D 3D TSV
US9175000 27 Buprenorphine analogs Purdue Pharma L.P. 08/08/162D 3D TSV
US9174969 73 Indoline scaffold SHP-2 inhibitors and cancer treatment method UNIVERSITY OF SOUTH FLORIDA 08/08/162D 3D TSV
US9175331 256 Inhibitors of human EZH2, and methods of use thereof Epizyme, Inc. 08/08/162D 3D TSV
US9174974 85 Macrocyclic factor VIIa inhibitors Bristol-Myers Squibb Company 08/08/162D 3D TSV
US9174999 20 Methods and compositions for studying, imaging, and treating pain The Board of Trustees of the Leland Stanford Junior University 08/08/162D 3D TSV
US9174993 27 N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals SANOFI 08/08/162D 3D TSV
US9175320 1 Processes for the preparation of (R)-2-(7-4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[B]indol-3-yl)acetic acid and salts thereof Arena Pharmaceuticals, Inc. 08/08/162D 3D TSV
US9175003 234 Substituted azoanthracene derivatives and intermediates for preparation thereof vTv Therapeutics LLC 08/08/162D 3D TSV
US9173884 107 Inhibitors of phosphodiesterase 11 (PDE11) Trustees of Boston College 08/02/162D 3D TSV
US9173935 18 Phospholipid drug analogs Telormedix SA 08/02/162D 3D TSV
US9174965 6 Pyrimidinylpiperidinyloxypyridone analogues as GPR119 modulators Bristol-Myers Squibb Company 08/02/162D 3D TSV
US9174940 29 TSH receptor antagonizing tetrahydroquinoline compounds Merck Sharp & Dohme B.V. 08/02/162D 3D TSV
US9169270 120 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators Actelion Pharmaceuticals Ltd. 08/01/162D 3D TSV
US9169260 399 Amidopyrazole inhibitors of interleukin receptor-associated kinases MERCK SHARP & DOHME CORP. 08/01/162D 3D TSV
US9173879 6 Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a ]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof Bristol-Myers Squibb Company 08/01/162D 3D TSV
US9173869 43 Mediators of hedgehog signaling pathways, compositions and uses related thereto CURIS, INC. 08/01/162D 3D TSV
US9169246 207 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof SANOFI 08/01/162D 3D TSV
US9073941 179 Compounds and methods for treating tuberculosis infection Academia Sinica 07/26/162D 3D TSV
US9169224 209 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase Janssen Pharmaceutica NV 07/26/162D 3D TSV
US9169243 45 Apoptosis signal-regulating kinase inhibitors Gilead Sciences, Inc. 07/25/162D 3D TSV
US9169209 118 Compounds and compositions for the inhibition of NAMPT FORMA TM, LLC 07/25/162D 3D TSV
US9169252 645 Heteroaryl substituted nicotinamide compounds Bristol-Myers Squibb Company 07/25/162D 3D TSV
US9169259 92 Imidazopyridazine compounds HOFFMANN-LA ROCHE INC. 07/25/162D 3D TSV
US9169240 92 Ketone linked benzothiazole inhibitors of endothelial lipase Bristol-Myers Squibb Company 07/25/162D 3D TSV
US9079895 129 Morpholino compounds, uses and methods University of Dundee 07/25/162D 3D TSV
US9169234 24 Sepiapterin reductase inhibitors for the treatment of pain Children's Medical Center Corporation 07/25/162D 3D TSV
US9163017 17 Anti-viral compounds ABBVIE INC. 07/18/162D 3D TSV
US9168247 6 Beta carboline derivatives useful in the treatment of proliferative disorders FACULTES UNIVERSITAIRES NOTRE DAME DE LA PAIX; UNIVERSITE LIBRE BRUXELLES 07/18/162D 3D TSV
US9163012 94 Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 Vitae Pharmaceuticals, Inc. 07/18/162D 3D TSV
US9163011 106 Oxazine derivatives and their use in the treatment of disease NOVARTIS AG 07/18/162D 3D TSV
US9163042 24 Prodrugs of pyridone amides useful as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED 07/18/162D 3D TSV
US9163015 90 Pyrazolopyridine, pyrarolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction Vanderbilt University 07/18/162D 3D TSV
US9169205 200 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 07/18/162D 3D TSV
US9163021 236 Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors Pfizer Limited 07/18/162D 3D TSV
US9168248 27 Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase Merck Canada Inc. 07/18/162D 3D TSV
US9163040 1 Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors NOVARTIS AG 07/18/162D 3D TSV
US9163013 34 Use of 1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. 07/18/162D 3D TSV
US9162979 50 1,5-Diary1-2-alkylpyrrole-3-substituted nitro esters, selective COX-2 inhibitors and nitric oxide donors ROTTAPHARM BIOTECH S.R.L. 07/11/162D 3D TSV
US9161945 2 4-isopropyl-6-methoxyphenyl glucitol compound TAISHO PHARMACEUTICAL CO., LTD. 07/11/162D 3D TSV
US9163003 106 4-piperidinyl compounds for use as tankyrase inhibitors NOVARTIS AG 07/11/162D 3D TSV
US9163007 94 5-substituted indazoles as kinase inhibitors AbbVie Inc. 07/11/162D 3D TSV
US9169182 4 Chrysophaentin analogs that inhibit FtsZ protein THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 07/11/162D 3D TSV
US9162991 55 Cinnamoyl inhibitors of transglutaminase University of Ottawa 07/11/162D 3D TSV
US9156822 144 Functionally selective ligands of dopamine D2 receptors The University of North Carolina at Chapel Hill 07/11/162D 3D TSV
US9163010 3 Indolinone protein kinase inhibitors Beta Pharma, Inc. 07/11/162D 3D TSV
US9163008 122 Pyrimidines as sodium channel blockers Purdue Pharma, L.P. 07/11/162D 3D TSV
US9161939 7 Pyrrolo[2,3-d]pyrimidine compounds Zoetis Services LLC 07/11/162D 3D TSV
US9168255 39 Quinazoline compounds as sodium channel blockers Purdue Pharma L.P. 07/11/162D 3D TSV
US9162983 5 Reactivators of organophosphorous inhibited acetylcholinesterase SOUTHWEST RESEARCH INSTITUTE 07/11/162D 3D TSV
US9156845 422 4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitors Pfizer Inc. 06/30/162D 3D TSV
US9161922 34 Amine oxidase inhibitors Case Western Reserve University 06/30/162D 3D TSV
US9156856 44 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases AbbVie Inc. 06/30/162D 3D TSV
US9156831 41 Chemical compounds AstraZeneca AB 06/30/162D 3D TSV
US9156829 308 Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists TAKEDA PHARMACEUTICAL COMPANY LIMITED 06/30/162D 3D TSV
US9161924 6 Factor IXa inhibitors Merck Sharp & Dohme Corp. 06/30/162D 3D TSV
US9156830 87 Heterocyclic compounds SHIONOGI & CO., LTD. 06/30/162D 3D TSV
US9156852 39 Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases HANMI PHARM. CO., LTD 06/30/162D 3D TSV
US9156848 4 Treating diabetes with dipeptidyl peptidase-IV inhibitors Merck Sharp & Dohme Corp. 06/30/162D 3D TSV
US9156836 5 Tricyclic triazole compounds that modulate HSP90 activity Synta Pharmaceuticals Corp. 06/30/162D 3D TSV
US9150566 561 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-YL)picolinamide derivatives as orexin receptor antagonists ACTELION PHARMACEUTICALS LTD. 06/20/162D 3D TSV
US9150578 174 5,8-dihydro-6H-pyrazolo[3,4-h]quinazolines as IGF-1R/IR inhibitors Boehringer Ingelheim International GmbH 06/20/162D 3D TSV
US9150526 208 Biaryl-propionic acid derivatives and their use as pharmaceuticals Sanofi 06/20/162D 3D TSV
US9155743 90 Bicyclic heterocycle compounds and their uses in therapy ASTEX THERAPEUTICS LIMITED 06/20/162D 3D TSV
US9150583 8 Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation Boehringer Ingelheim International GmbH 06/20/162D 3D TSV
US9150577 239 Heterocyclic compounds containing an indole core Boehringer Ingelheim International GmbH 06/20/162D 3D TSV
US9156811 829 N-myristoyl transferase inhibitors Univeristy of Dundee 06/20/162D 3D TSV
US9150581 30 Nicotinic receptor compounds RESEARCH TRIANGLE INSTITUTE; THE REGENTS OF THE UNIVERSITY OF MICHIGAN; VIRGINIA COMMONWEALTH UNIVERSITY 06/20/162D 3D TSV
US9150579 6 Selective PI3K delta inhibitors RHIZEN PHARMACEUTICALS SA 06/20/162D 3D TSV
US9156810 66 Treatment of inflammatory bowel disease Allergan, Inc. 06/20/162D 3D TSV
US9150519 242 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis MERCK SERONO SA 06/14/162D 3D TSV
US9145414 77 1,2,4-triazine-6-carboxamide derivative TAIHO PHARMACEUTICAL CO., LTD. 06/13/162D 3D TSV
US9149477 5 5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta ICOS Corporation 06/13/162D 3D TSV
US9145402 38 Aminopyrimidine derivatives as LRRK2 modulators Genentech, Inc. 06/13/162D 3D TSV
US9145391 266 Bipyridylaminopyridines as Syk inhibitors Merck Sharp & Dohme Corp.; Merck Canada Inc. 06/13/162D 3D TSV
US9145380 240 Bis-(sulfonylamino) derivatives for use in therapy Astrazeneca AB 06/13/162D 3D TSV
US9144538 75 Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin The Procter & Gamble Company 06/13/162D 3D TSV
US9145392 772 Imidazole amines as modulators of kinase activity Merck Patent GmbH 06/13/162D 3D TSV
US9145419 10 Imidazopyridazinyl compounds Bristol-Myers Squibb Company 06/13/162D 3D TSV
US9150527 8 Metalloenzyme inhibitor compounds Innocrin Pharmaceuticals, Inc. 06/13/162D 3D TSV
US9149492 26 Method for selectively inhibiting ACAT1 in the treatment of alzheimer's disease Trustees of Dartmouth College 06/13/162D 3D TSV
US9145354 231 Pharmaceutical compounds ASTEX THERAPEUTICS LIMITED 06/13/162D 3D TSV
US9145426 38 Pyrrolidine-fused thiadiazine dioxide compounds as BACE inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 06/13/162D 3D TSV
US9145412 77 Selective HDAC1 and HDAC2 inhibitors ACETYLON PHARMACEUTICALS, INC. 06/13/162D 3D TSV
US9145418 10 Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-ones as protein kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 06/13/162D 3D TSV
US9145408 44 Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators Purdue Pharma L.P.; Shionogi & Co., Ltd. 06/13/162D 3D TSV
US9150544 176 Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application Sanofi 06/13/162D 3D TSV
US9150546 325 Triazine derivative and pharmaceutical composition comprising the same SHIONOGI & CO., LTD. 06/13/162D 3D TSV
US9139578 26 Amide or urea containing benzothiazole inhibitors of endothelial lipase Bristol-Myers Squibb Company 06/06/162D 3D TSV
US9139593 21 Azetidine compounds, compositions and methods of use HOFFMANN-LA ROCHE INC. 06/06/162D 3D TSV
US9138393 75 Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin The Procter & Gamble Company 06/06/162D 3D TSV
US9139568 167 Heterocyclic carboxamides as modulators of kinase activity Merck Patent GmbH 06/06/162D 3D TSV
US9139585 51 Inhibitors of the Renal Outer Medullary Potassium channel Merck Sharp & Dohme Corp. 06/06/162D 3D TSV
US9138431 13 Methods of treatment of histamine H-4 receptor-related pruritus BRIDGE PHARMA, INC. 06/06/162D 3D TSV
US9138494 8 Radiolabeled PDE10A ligands AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG 06/06/162D 3D TSV
US9139529 80 Substituted quinoxalines as sodium channel modulators VERTEX PHARMACEUTICALS INCORPORATED 06/06/162D 3D TSV
US9139577 328 Sulfoximine substituted quinazolines for pharmaceutical compositions Boehringer Ingelheim International GmbH 06/06/162D 3D TSV
US9139546 32 Tri-aryl/heteroaromatic cannabinoids and use thereof The University of Tennessee Research Foundation 06/06/162D 3D TSV
US9138423 2 Use of inhibitors of porphobilinogen deaminase in the treatment of congenital erythropoietic porphyria Asociación Centro de Investigación Cooperativa en Biociencias—CIC Biogune 06/06/162D 3D TSV
US9133180 33 Aurora and FLT3 kinases modulators SAREUM LIMITED 05/23/162D 3D TSV
US8772323 260 Benzoxazole- and tetrahydrobenzoxazole-substituted pyridazinones as GPR119 agonists Boehringer Ingelheim International GmbH 05/23/162D 3D TSV
US9133171 193 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group Bayer Intellectual Property GmbH 05/23/162D 3D TSV
US8829029 164 Dual modulators of 5HT2A and D3 receptors Hoffmann-La Roche Inc. 05/23/162D 3D TSV
US9133183 27 Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities Deciphera Pharmaceuticals, LLC 05/23/162D 3D TSV
US9133201 12 Inhibitors of Bruton's tyrosine kinase PHARMACYCLICS, INC. 05/23/162D 3D TSV
US9133197 12 Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. 05/23/162D 3D TSV
US8865745 19 Pyrazolone derivatives as PDE4 inhibitors Takeda GmbH 05/23/162D 3D TSV
US9133199 2 Pyrimidine derivatives as protein kinase inhibitors Cyclacel Limited 05/23/162D 3D TSV
US9133182 37 Selective androgen receptor modulators Radius Health, Inc. 05/23/162D 3D TSV
US9133187 85 Serine/threonine kinase inhibitors ARRAY BIOPHARMA INC.; GENENTECH, INC. 05/23/162D 3D TSV
US9132129 8 Antiviral compounds KATHOLIEKE UNIVERSITEIT LEUVEN 05/16/162D 3D TSV
US9133148 91 Carbamate compounds and of making and using same The Scripps Research Institute; Abide Therapeutics, Inc. 05/16/162D 3D TSV
US9133157 134 HIV protease inhibitors Merck Canada Inc. 05/16/162D 3D TSV
US9133134 1 Inhibitors of bruton's tyrosine kinase PHARMACYCLICS LLC 05/16/162D 3D TSV
US9132134 10 Methods for treating GI tract disorders Neurogastrx, Inc. 05/16/162D 3D TSV
US9133125 72 Morphan and morphinan analogues, and methods of use ALKERMES PHARMA IRELAND LIMITED 05/16/162D 3D TSV
US9133168 168 Pyrimidine derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors SANOFI 05/16/162D 3D TSV
US9133131 27 Pyrimidine diol amides as sodium channel blockers Purdue Pharma L.P. 05/16/162D 3D TSV
US9133160 15 Substituted benzimidazole and imidazopyridine compounds useful as CYP17 modulators Bristol-Meyers Squibb Company 05/16/162D 3D TSV
US9133162 13 Substituted quinoline compounds and methods of use SUNSHINE LAKE PHARMA CO., LTD.; CALITOR SCIENCES, LLC 05/16/162D 3D TSV
US9133105 4 Transcription factor modulators C&C BIOPHARMA, LLC 05/16/162D 3D TSV
US9126978 10 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties The Regents of the University of Michigan 05/09/162D 3D TSV
US9126979 24 Compounds for inhibiting the interaction of BCL2 with binding partners Novartis AG 05/09/162D 3D TSV
US9126980 90 Compounds for inhibiting the interaction of BCL2 with binding partners Novartis AG 05/09/162D 3D TSV
US9127027 37 Epoxyeicosatrienoic acid analogs and methods of making and using the same The Medical College of Wisconsin, Inc.; The Board of Regents of the University of Texas System 05/09/162D 3D TSV
US9126987 25 Inhibitors of glutaminyl cyclase PROBIODRUG AG 05/09/162D 3D TSV
US9127005 20 Isoform selective phospholipase D inhibitors Vanderbilt University 05/09/162D 3D TSV
US9126952 67 Morpholinylquinazolines Merck Patent GmbH 05/09/162D 3D TSV
US9126973 76 Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases CAYMAN CHEMICAL COMPANY, INCORPORATED 05/09/162D 3D TSV
US9126957 10 Selective glycosidase inhibitors and uses thereof MERCK SHARP & DOHME CORP.; ALECTOS THERAPEUTICS, INC. 05/09/162D 3D TSV
US9127001 68 Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them Sanofi 05/09/162D 3D TSV
US9126976 41 Substituted benzopiperazines as CETP inhibitors Merck Sharp & Dohme Corp. 05/09/162D 3D TSV
US9125915 17 Antitumor agent Mitsubishi Tanabe Pharma Corporation 05/02/162D 3D TSV
US9125913 853 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases AbbVie Inc. 05/02/162D 3D TSV
US9126948 14 Pyrimidine-4,6-diamine derivatives as PI3K inhibitors Incyte Holdings Corporation; Incyte Corporation 05/02/162D 3D TSV
US9120812 515 Pyrimidooxazocine derivatives as mTOR-inhibitors Sanofi 05/02/162D 3D TSV
US9120838 4 Saccharide conjugates Curators of the University of Missouri 05/02/162D 3D TSV
US9120808 141 Substituted clavulanic acid NABRIVA THERAPEUTICS AG 05/02/162D 3D TSV
US9126947 6 Substituted pyridazine carboxamide compounds Xcovery Holding Company LLC 05/02/162D 3D TSV
US9126931 266 Tetracyclic compound Chugai Seiyaku Kabushiki Kaisha 05/02/162D 3D TSV
US9126941 39 Treatment of hyperproliferative disorders with diarylhydantoin compounds The Regents of the University of California 05/02/162D 3D TSV
US9120798 50 Amino-heteroaryl 7-hydroxy-spiropiperidine indolinyl antagonists of P2Y1 receptor Bristol-Myers Squibb Company 04/25/162D 3D TSV
US9120769 172 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline Boehringer-Ingelheim International GmbH 04/25/162D 3D TSV
US9120771 46 Azetidine derivative and antidepressant composition including the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 04/25/162D 3D TSV
US9120772 6 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases GALDERMA RESEARCH & DEVELOPMENT 04/25/162D 3D TSV
US9120780 37 Indole or indazole derivative or salt thereof TAIHO PHARMACEUTICAL CO., LTD. 04/25/162D 3D TSV
US9120791 119 Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD 04/25/162D 3D TSV
US9120797 66 Process for preparing spirocyclic cyclohexane compounds, compositions containing such compounds and method of using such compounds Gruenenthal GmbH 04/25/162D 3D TSV
US9120785 12 Pyridyl aminopyridines as Syk inhibitors Merck Sharp & Dohme Corp. 04/25/162D 3D TSV
US9120781 7 Selective glycosidase inhibitors and uses thereof Simon Fraser University; Merck Sharp & Dohme Corp.; Alectos Therapeutics Inc. 04/25/162D 3D TSV
US9120807 28 Thienopyrimidine compounds Vernalis (R&D) Ltd. 04/25/162D 3D TSV
US9120786 14 Triazine carboxamides as sodium channel blockers Purdue Pharma, L.P. 04/25/162D 3D TSV
US9115121 70 1,3,5-triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof Sanofi 04/18/162D 3D TSV
US9119845 20 Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase Amicus Therapeautics, Inc. 04/18/162D 3D TSV
US9115122 39 Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK) UNIVERSITY OF MARYLAND, BALTIMORE 04/18/162D 3D TSV
US9120744 43 Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism THE REGENTS OF THE UNIVERSITY OF MICHIGAN; EASTERN MICHIGAN UNIVERSITY 04/18/162D 3D TSV
US9120752 40 Pyridine compounds as sodium channel blockers Purdue Pharma, L.P. 04/18/162D 3D TSV
US9120749 650 Quinoline derivatives and MELK inhibitors containing the same ONCOTHERAPY SCIENCE, INC. 04/18/162D 3D TSV
US9120761 34 Selective FAK inhibitors Cancer Therapeutics CRC PTY LTD 04/18/162D 3D TSV
US9120756 63 Substituted phenylureas and phenylamides as vanilloid receptor ligands Gruenenthal GmbH 04/18/162D 3D TSV
US9120745 4 Triazole compounds that modualte HSP90 activity Synta Pharmaceuticals Corp. 04/18/162D 3D TSV
US9115089 2 Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds CONFLUENCE LIFE SCIENCES, INC. 04/12/162D 3D TSV
US9115140 33 Thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof SANOFI 04/12/162D 3D TSV
US9115126 10 1H-[1,2,3]triazolo[4,5-c]pyridine-4-carbonitrile derivatives Merck Sharp & Dohme B.V. 04/11/162D 3D TSV
US9096593 403 Compounds and methods for kinase modulation, and indications therefor Plexxikon Inc. 04/11/162D 3D TSV
US9115083 75 Compounds from Antrodia cinnamomea and use thereof SIMPSON BIOTECH CO., LTD. 04/11/162D 3D TSV
US9115085 1 Crystalline forms of a prolyl hydroxylase inhibitor FIBROGEN, INC. 04/11/162D 3D TSV
US9115082 9 Dipeptidyl-peptidase-IV inhibitors for treatment of type 2 diabetes complex with hypertension TBA 04/11/162D 3D TSV
US9115116 27 Dual action inhibitors against histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme a reductase Academia Sinica; National Taiwan University 04/11/162D 3D TSV
US9115144 5 Fused heterocyclic derivative and pharmaceutical use thereof KISSEI PHARMACEUTICAL CO., LTD. 04/11/162D 3D TSV
US9115102 45 N-[2-hydroxycarbamoyl-2-(piperazinyl) ethyl] benzamide compounds, their preparation and their use as TACE inhibitors GALDERMA RESEARCH & DEVELOPMENT 04/11/162D 3D TSV
US9115117 280 Substituted piperidine compounds and their use as orexin receptor modulators JANSSEN PHARMACEUTICA NV 04/11/162D 3D TSV
US9102669 100 Substituted piperidinyl-pyridazinyl derivatives useful as SCD 1 inhibitors Janssen Pharmaceutica NV 04/05/162D 3D TSV
US9102686 152 5,6,7,8,9,10-hexahydro-6,10-epimino[1,2,4]triazolo[4,3-a]azocines as P2X7 modulators Janssen Pharmaceutica NV 04/04/162D 3D TSV
US9102591 244 Benzamides H. Lundbeck A/S 04/04/162D 3D TSV
US9102637 93 Bicyclic thiazole compounds CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER 04/04/162D 3D TSV
US9102622 63 Fatty acid amide hydrolase inhibitors University of Connecticut 04/04/162D 3D TSV
US9096627 6 Hydroxamic acid derivatives Purdue Pharmaceutical Products L.P. 04/04/162D 3D TSV
US9102599 15 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases Bristol-Myers Squibb Company 04/04/162D 3D TSV
US9114126 10 Na/K-ATPase ligands, ouabain antagonists, assays and uses thereof THE UNIVERSITY OF TOLEDO 04/04/162D 3D TSV
US9115061 17 Naphthalene-based inhibitors of anti-apoptotic proteins BURNHAM INSTITUTE FOR MEDICAL RESEARCH 04/04/162D 3D TSV
US9102670 445 Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors KUDOS PHARMACEUTICALS LIMITED 04/04/162D 3D TSV
US9102656 12 Use of rosuvastatin lactols as medicaments RedX Pharma Limited 04/04/162D 3D TSV
US9096559 134 4-carboxybenzylamino derivatives as histone deacetylase inhibitors Merck Sharp & Dohme Corp. 03/28/162D 3D TSV
US9096595 51 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin D2 receptor modulators Actelion Pharmaceuticals Ltd 03/28/162D 3D TSV
US9096579 258 Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments Boehringer Ingelheim International GmbH 03/28/162D 3D TSV
US9238653 54 Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM; MMV MEDICINES FOR MALARIA VENTURE; UNIVERSITY OF WASHINGTON 03/28/162D 3D TSV
US9096601 108 Arylamino purine derivatives, preparation method and pharmaceutical use thereof CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.; Sichuan University 03/28/162D 3D TSV
US9096580 5 Benzofuran derivatives for the treatment of hepatitis C Bristol-Myers Squibb Company 03/28/162D 3D TSV
US9096589 112 Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors H. Lundbeck A/S 03/28/162D 3D TSV
US9096541 28 Inhibition of memapsin 1 cleavage in the treatment of diabetes Oklahoma Medical Research Foundation; Purdue Research Foundation 03/28/162D 3D TSV
US9096594 15 Kinase inhibitors and methods of use thereof The Broad Institute, Inc.; The General Hospital Corporation; Dana-Farber Cancer Institute, Inc. 03/28/162D 3D TSV
US9096515 36 Methods of using cycloalkylmethylamine derivatives REVIVA PHARMACEUTICALS, INC. 03/28/162D 3D TSV
US9096596 332 P2X7 modulators JANSSEN PHARMACEUTICA NV 03/28/162D 3D TSV
US9096606 64 Quarternized buprenorphine analogs Purdue Pharma, L.P. 03/28/162D 3D TSV
US9096549 46 Selective HDAC3 inhibitors ACETYLON PHARMACEUTICALS, INC. 03/28/162D 3D TSV
US9089569 190 1,2,6-substituted benzimidazoles as flap modulators JANSSEN PHARMACEUTICA NV 03/21/162D 3D TSV
US9090564 130 5-alkynyl-pyridines Boehringer Ingelheim International GmbH 03/21/162D 3D TSV
US9090562 334 Aryl- or heteroaryl-substituted benzene compounds Epizyme, Inc. 03/21/162D 3D TSV
US9090628 126 Benzoxazepin compounds selective for PI3K P110 delta and methods of use GENENTECH, INC. 03/21/162D 3D TSV
US9090657 22 Compound and methods for its production NEUROVIVE PHARMACEUTICAL AB 03/21/162D 3D TSV
US9090596 84 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies GALDERMA RESEARCH & DEVELOPMENT 03/21/162D 3D TSV
US9090589 25 Specific nNOS inhibitors for the therapy and prevention of human melanoma Northwestern University; The Regents of the University of California 03/21/162D 3D TSV
US9090618 172 Substituted benzimidazole-type piperidine compounds and uses thereof Purdue Pharma L.P. 03/21/162D 3D TSV
US9085584 356 Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disorders Boehringer Ingelheim International GmbH 03/21/162D 3D TSV
US9090625 9 Therapeutic pyrazolyl thienopyridines THESAN PHARMACEUTICALS, INC. 03/21/162D 3D TSV
US9085572 10 4-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases Bayer Intellectual Property GmbH 03/16/162D 3D TSV
US9085531 117 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin Albany Molecular Research, Inc.; Bristol-Myers Squibb Company 03/14/162D 3D TSV
US9085555 773 Complement pathway modulators and uses thereof NOVARTIS AG 03/14/162D 3D TSV
US9085549 48 Compounds for the treatment of neurodegenerative diseases PROTEOTECH INC 03/14/162D 3D TSV
US9079902 124 Heteroaryl sodium channel inhibitors AMGEN INC. 03/14/162D 3D TSV
US9085571 30 Nonpeptide HIV-1 protease inhibitors Purdue Research Foundation 03/14/162D 3D TSV
US9085576 846 Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use AMGEN INC. 03/14/162D 3D TSV
US9085540 31 Pyrazinecarboxamide compound Astellas Pharma Inc. 03/14/162D 3D TSV
US9079913 185 Spiro-oxindole MDM2 antagonists THE REGENTS OF THE UNIVERSITY OF MICHIGAN 03/14/162D 3D TSV
US9079929 29 Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors Bristol-Myers Squibb Company 03/14/162D 3D TSV
US9073940 429 Tricyclic pyrazol amine derivatives MERCK SERONO SA 03/09/162D 3D TSV
US9079866 833 Flap modulators JANSSEN PHARMACEUTICA NV 03/07/162D 3D TSV
US9079834 11 HIV protease inhibitors Merck Canada Inc. 03/07/162D 3D TSV
US9073926 105 Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core Boehringer Ingelheim International GmbH 03/07/162D 3D TSV
US9073939 7 Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof Bayer Intellectual Property GmbH 03/07/162D 3D TSV
US9073931 108 Liver X receptor modulators Vitae Pharmaceuticals, Inc. 03/07/162D 3D TSV
US9079852 20 NMDA receptor antagonists for neuroprotection Emory University; NeurOp, Inc. 03/07/162D 3D TSV
US9073936 8 Organic compounds INTRA-CELLULAR THERAPIES, INC. 03/07/162D 3D TSV
US9079880 163 Rho kinase inhibitors Boehringer Ingelheim International GmbH 03/07/162D 3D TSV
US9079868 1 Selective glycosidase inhibitors and uses thereof Simon Fraser University 03/07/162D 3D TSV
US9079906 27 Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments Sanofi 03/07/162D 3D TSV
US9073893 60 3-Oxo-2,3-dihydro-1H-indazole-4-carboxamide derivatives as PARP-1 inhibitors NERVIANO MEDICAL SCIENCES S.R.L. 02/29/162D 3D TSV
US9073870 181 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use Boehringer Ingelheim International GmbH 02/29/162D 3D TSV
US9073917 27 Anti-cancer compound and pharmaceutical composition containing the same SANOFI 02/29/162D 3D TSV
US9073925 10 Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof Albany Molecular Research, Inc. 02/29/162D 3D TSV
US9073881 153 Benzoic acid derivatives HOFFMANN-LA ROCHE INC. 02/29/162D 3D TSV
US9073876 335 Flap modulators JANSSEN PHARMACEUTICA NV 02/29/162D 3D TSV
US9073882 9 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 02/29/162D 3D TSV
US9073869 37 Method of using substituted 2-Aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C Boehringer Ingelheim International GmbH 02/29/162D 3D TSV
US9073911 108 Pyrazole derivatives HOFFMANN-LA ROCHE INC. 02/29/162D 3D TSV
US9073922 368 Pyrrolo[2,3-B]pyridine CDK9 kinase inhibitors AbbVie, Inc. 02/29/162D 3D TSV
US9073906 44 Sulfamide derivative having an adamantyl group and its pharmaceutically acceptable salt KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY 02/29/162D 3D TSV
US9067924 24 1,4 thiazepines/sulfones as BACE1 and/or BACE2 inhibitors HOFFMANN-LA ROCHE INC. 02/22/162D 3D TSV
US9067937 113 1,5-naphthyridine derivatives and MELK inhibitors containing the same OncoTherapy Science, Inc. 02/22/162D 3D TSV
US9067931 20 2-heteroaryl carboxamides BAYER INTELLECTUAL PROPERTY GMBH 02/22/162D 3D TSV
US9067949 216 Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia Albany Molecular Research, Inc. 02/22/162D 3D TSV
US9067922 243 Chemical compounds Pfizer Limited 02/22/162D 3D TSV
US9073853 157 Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists SANOFI 02/22/162D 3D TSV
US9062043 371 Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators SENHWA BIOSCIENCES, INC. 02/22/162D 3D TSV
US9073821 60 Hydroxamic acid derivative TAISHO PHARMACEUTICAL CO., LTD; TOYAMA CHEMICAL CO., LTD. 02/22/162D 3D TSV
US9067935 114 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators Janssen Pharmaceutica, NV 02/22/162D 3D TSV
US9073833 17 Oxime-based compound, pharmaceutical composition containing the same and method for preparing the same Chang Gung University 02/22/162D 3D TSV
US9067945 10 Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes Boehringer Ingehleim International GmbH 02/22/162D 3D TSV
US9067917 220 1,2,5-substituted benzimidazoles as FLAP modulators Janssen Pharmaceutica NV 02/16/162D 3D TSV
US9067871 405 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG; AbbVie Inc. 02/16/162D 3D TSV
US9062066 13 Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases and pharmaceutical composition containing same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 02/16/162D 3D TSV
US9066954 107 Fused heterocyclic derivatives and methods of use Amgen Inc. 02/16/162D 3D TSV
US9067888 20 Inhibitors of protein kinases AstraZeneca AB 02/16/162D 3D TSV
US9062070 238 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 02/16/162D 3D TSV
US9062059 20 Pyrimidine PDE10 inhibitors Merck Sharp & Dohme Corp. 02/16/162D 3D TSV
US9062078 702 Substituted 7-azabicyles and their use as orexin receptor modulators JANSSEN PHARMACEUTICA NV 02/16/162D 3D TSV
US9062060 11 Substituted imidazo[2,1-A]isoindoles as PDE10 inhibitors H. Lundbeck A/S 02/16/162D 3D TSV
US9067914 241 Tropomyosin-related kinase (TRK) inhibitors Genzyme Corporation 02/16/162D 3D TSV
US9061041 6 2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases Merck Sharp & Dohme Corp. 02/09/162D 3D TSV
US9062004 58 Cannabinoid-2 agonists Allergan, Inc. 02/09/162D 3D TSV
US9062048 173 Cyclohexyl-azetidinyl antagonists of CCR2 Janssen Pharmaceutica NV 02/09/162D 3D TSV
US9062026 89 Fused pyrimidines and substituted quinazolines as inhibitors of p97 Cleave Biosciences, Inc. 02/09/162D 3D TSV
US9056859 11 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 02/09/162D 3D TSV
US9061023 2 Management and treatment of benign prostatic hyperplasia CSIR 02/09/162D 3D TSV
US9056865 149 Pyridine-2-derivatives as smoothened receptor modulators Pfizer Inc. 02/09/162D 3D TSV
US9056863 3 Substituted 2,3,5,9,9B-pentaazacyclopenta[a]naphthalenes and uses thereof H. Lundbeck A/S 02/09/162D 3D TSV
US9062045 143 Triazolopyridine compounds Novartis AG 02/09/162D 3D TSV
US9056843 460 Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease NOVARTIS AG 02/09/162D 3D TSV
US9056847 4 Activity based probes (ABPs) interacting with glycosidases ACADEMISCH MEDISCH CENTRUM BIJ UNIVERSITEIT VAN AMSTERDAM 01/25/162D 3D TSV
US9051313 18 Apoptosis signal-regulating kinase inhibitors Gildead Sciences, Inc. 01/25/162D 3D TSV
US9056836 11 Benzomorphan analogs and the use thereof Purdue Pharma L.P. 01/25/162D 3D TSV
US9051321 28 Heterocyclic acrylamides and their use as pharmaceuticals FAB PHARMA S.A.S. 01/25/162D 3D TSV
US9056857 7 Methods for treating or preventing cancer and neurodegenerative diseases SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 01/25/162D 3D TSV
US9056832 152 Pyridine compounds and the users thereof Purdue Pharma L.P. 01/25/162D 3D TSV
US9051279 174 Substituted isoquinolinones and quinazolinones Novartis AG 01/25/162D 3D TSV
US9051311 173 Sulfamide sodium channel inhibitors AMGEN INC. 01/25/162D 3D TSV
US9051280 10 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG; AbbVie Inc. 01/25/162D 3D TSV
US9051329 8 Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors Merck Sharp & Dohme Corp. 01/25/162D 3D TSV
US9108973 73 3,5-disubstituted alkynylbenzene compound and salt thereof Taiho Pharmaceutical Co., Ltd. 01/19/162D 3D TSV
US9108978 16 Antimicrobial compounds Monash University; Adelaide Research & Innovation Pty Ltd 01/19/162D 3D TSV
US9108983 174 Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER; VERNALIS (R&D) LTD 01/19/162D 3D TSV
US9108984 2 Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors Incyte Corporation; Incyte Holdings Corporation 01/19/162D 3D TSV
US9108950 12 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors Respivert, Ltd. 01/18/162D 3D TSV
US9108956 11 Cyclic ether DGAT1 inhibitorscyclic ether DGAT1 inhibitors NOVARTIS AG 01/18/162D 3D TSV
US9051265 89 N-benzylindole modulators of PPARG The Scripps Research Institute 01/18/162D 3D TSV
US9051270 160 Pyridone amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED 01/18/162D 3D TSV
US9051240 7 Substituted 2-[2-(phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators Newron Pharmaceuticals S.P.A. 01/18/162D 3D TSV
US9045501 28 5-HT3 receptor modulators, methods of making, and use thereof Albany Molecular Research, Inc. 01/11/162D 3D TSV
US9108903 76 Amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED 01/11/162D 3D TSV
US9107954 14 Bivalent ligands for the treatment of neurological disorders Virginia Commonwealth University 01/11/162D 3D TSV
US9107923 81 Heteroaromatic compounds and their use as dopamine D1 ligands Pfizer Inc. 01/11/162D 3D TSV
US9045498 25 Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 01/11/162D 3D TSV
US9045500 32 Inhibitors of beta-secretase Vitae Pharmaceuticals, Inc. 01/11/162D 3D TSV
US9108947 18 Inhibitors of the Renal Outer Medullary Potassium channel Merck Sharp & Dohme Corp. 01/11/162D 3D TSV
US9045524 160 Selective caspase inhibitors and uses thereof NOVAGENESIS FOUNDATION 01/11/162D 3D TSV
US9108951 16 Substituted 5,6,7,8-tetrahydro-1,6-naphthyridines as factor XIa inhibitors Bristol-Myers Squibb Company 01/11/162D 3D TSV
US9108905 19 TRPA1 antagonists AbbVie Inc. 01/11/162D 3D TSV
US9045468 186 2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin Albany Molecular Research, Inc.; Bristol-Myers Squibb Company 12/21/152D 3D TSV
US9045389 9 Biphenyl derivatives useful as glucagon receptor antagonists Janssen Pharmaceutica NV 12/21/152D 3D TSV
US9040694 20 Compounds and methods useful for directing stem cell differentiation Vanderbilt University 12/21/152D 3D TSV
US9040693 15 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof KISSEI PHARMACEUTICAL CO., LTD. 12/21/152D 3D TSV
US9040727 36 Histone deacetylase inhibitor of benzamides and use thereof Shanghai Institute of Pharmaceutical Industry; Sinopharm A-Think Pharmaceutical Co., Ltd.; Sinopharm A-Think Medical and Pharmaceutical Research & Development (Beijing) Co., Ltd. 12/21/152D 3D TSV
US9040691 47 Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors BAYER INTELLECTUAL PROPERTY GMBH 12/21/152D 3D TSV
US9040714 139 IRE-1α inhibitors MannKind Corporation 12/21/152D 3D TSV
US9045483 13 Inhibition of small ubiquitin-like modifier enzymes with substituted pyrrolo[2,3-b]quinoxalines City of Hope; Sanford-Burnham Medical Research Institute 12/21/152D 3D TSV
US9045459 3 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG; AbbVie Inc. 12/21/152D 3D TSV
US9040717 10 Pyrazole-amide compounds and pharmaceutical use thereof JAPAN TOBACCO INC. 12/21/152D 3D TSV
US9040518 72 Chemical compounds GlaxoSmithKline LLC 12/14/152D 3D TSV
US9040528 203 Chemical compounds 542 AstraZeneca AB 12/14/152D 3D TSV
US9040501 5 Compositions and methods for treating cancer Otsuka Pharmaceutical Co., Ltd. 12/14/152D 3D TSV
US9040663 202 Melanocortin receptor-specific peptides AstraZeneca AB 12/14/152D 3D TSV
US9040509 6 Method of treating human skin and a skin care composition for use in such a method Pantarhei Bioscience B.V. 12/14/152D 3D TSV
US9035059 157 Nitrogen-containing condensed heterocyclic compound TAISHO PHARMACEUTICAL CO., LTD. 12/14/152D 3D TSV
US9035074 168 Pyrrolo[2,3-D]pyrimidine derivatives Pfizer Inc. 12/14/152D 3D TSV
US9040542 2 Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pryimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea VERTEX PHARMACEUTICALS INCORPORATED 12/14/152D 3D TSV
US9040534 279 [1,2,4]triazolo[4,3-a]pyrazines as P2X7 modulators Janssen Pharmaceutica NV 12/14/152D 3D TSV
US9034921 203 Diphenylmethane derivatives as SGLT2 inhibitors GREEN CROSS CORPORATION 12/08/152D 3D TSV
US9035066 3 Method of using 4,5,6,7-tetrahydroimidazo[4,5-C]pyridine compounds Proximagen Limited 12/08/152D 3D TSV
US9035062 3 Process for preparing a compound useful for producing an optically active diazabicyclooctane compound MEIJI SEIKA PHARMA CO., LTD. 12/08/152D 3D TSV
US9034856 51 17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative Bayer Intellectual Property GmbH 12/07/152D 3D TSV
US9034886 5 4-aminoquinazoline derivatives and uses thereof Shanghai Institute of Pharmaceutical Industry; Jiangsu Hengyi Pharmaceutical Co., Ltd. 12/07/152D 3D TSV
US9034574 20 Agents for reversing epigenetic silencing of genes The Johns Hopkins University 12/07/152D 3D TSV
US9034899 81 Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof Albany Molecular Research, Inc. 12/07/152D 3D TSV
US9034874 20 Carbamate/urea derivatives NOVARTIS AG 12/07/152D 3D TSV
US9034897 44 Indanyl-substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicament, and pharmaceutical preparations comprising them SANOFI 12/07/152D 3D TSV
US9034907 36 Inhibitors of glutaminyl cyclase Probiodrug AG 12/07/152D 3D TSV
US9034866 815 Tricyclic compounds and methods of use therefor Genentech, Inc. 12/07/152D 3D TSV
US9029399 54 17α-hydroxylase/C17,20-lyase inhibitors Novartis AG 11/23/152D 3D TSV
US9029364 34 2,5-disubstituted thiomorpholine orexin receptor antagonists Merck Sharp & Dohme Corp. 11/23/152D 3D TSV
US9029393 22 Adenosine receptor ligands and uses thereof Kaldi Pharma, SAS 11/23/152D 3D TSV
US9029381 55 Cyclopropyl amide derivatives Astrazeneca AB 11/23/152D 3D TSV
US9029362 23 Iminothiadiazine dioxide compounds as brace inhibitors, compositions, and their use Merck Sharp & Dohme Corp. 11/23/152D 3D TSV
US9034303 10 Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof TBA 11/23/152D 3D TSV
US9034854 6 Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy PANTARHEI BIOSCIENCE B.V. 11/23/152D 3D TSV
US9029401 58 Sorafenib derivatives as sEH inhibitors The Regents of the University of California 11/23/152D 3D TSV
US9029370 276 Substituted benzamide derivatives Hoffmann-La Roche Inc. 11/23/152D 3D TSV
US9023767 2 γ-Secretase substrates and methods of use Memorial Sloan-Kettering Cancer Center 11/16/152D 3D TSV
US9023882 212 5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same Kissei Pharmaceutical Co., Ltd. 11/16/152D 3D TSV
US9029367 5 BACE inhibitors Eli Lilly and Company 11/16/152D 3D TSV
US9023865 687 Compounds that are ERK inhibitors Merck Sharp & Dohme Corp. 11/16/152D 3D TSV
US9024044 162 Heteroarylcarboxylic acid ester derivative Ajinomoto Co., Inc. 11/16/152D 3D TSV
US9029360 36 Pyrazolopyrimidines as metabotropic glutamate 5 receptor antagonists Boehringer Ingelheim International GmbH 11/16/152D 3D TSV
US9023849 22 Substituted fused imidazoles and pyrazoles and use thereof Bayer Intellectual Property GmbH 11/16/152D 3D TSV
US9029356 12 Substituted indazole derivatives active as kinase inhibitors Nerviano Medical Sciences S.R.L. 11/16/152D 3D TSV
US9018371 27 Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient FM Therapeutics Co., Ltd.; The United States of America, As Represented by the Secretary, Department of Health and Human Services, The Office of Technology Transfer, National Institutes of Health 11/11/152D 3D TSV
US9018381 66 Chemical compounds AstraZeneca AB 11/11/152D 3D TSV
US9023354 43 Combination therapy with MDM2 and EFGR inhibitors TBA 11/11/152D 3D TSV
US9018217 124 Phenylimidazole derivatives as PDE10A enzyme inhibitors H. Lundbeck A/S 11/11/152D 3D TSV
US9029559 503 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals SANOFI 11/11/152D 3D TSV
US9018213 12 Alicyclic[c] benzopyrone derivatives and uses thereof Huazhong University of Science & Technology; NHWA Pharma. Corporation 11/02/152D 3D TSV
US9018214 370 Bicyclic heterocycle compounds and their uses in therapy Astex Therapeutics Limited 11/02/152D 3D TSV
US9011882 20 Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereof The Board of Trustees of the Leland Stanford Junior University 11/02/152D 3D TSV
US9018255 7 Esters of (acyloxymethyl)acrylamide, a pharmaceutical composition containing them, and their use as inhibitors of the thioredoxin—thioredoxin reductase system Instytut Chemii Organicznej Polskiej Akademii Nauk; Warszawski Uniwersytet Medyczny 11/02/152D 3D TSV
US9012461 132 FAK inhibitors Cancer Therapeutics CRC Pty Ltd 11/02/152D 3D TSV
US9018234 8 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof Bayer Intellectual Property GmbH 11/02/152D 3D TSV
US9018391 16 Inhibitors of beta-secretase Boehringer Ingelheim International GmbH; Vitae Pharmaceuticals, Inc. 11/02/152D 3D TSV
US9018211 9 Inhibitors of the renal outer medullary potassium channel Merck Sharp & Dohme Corp. 11/02/152D 3D TSV
US9012475 26 Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a method for treatment of tumor Taiho Pharmaceutical Co., Ltd. 11/02/152D 3D TSV
US9012651 291 TRPV3 modulators AbbVie Inc. 11/02/152D 3D TSV
US9006269 19 Azetidine derivatives Vernalis (R&D) Ltd. 10/26/152D 3D TSV
US9006454 111 Dihydroorotate dehydrogenase inhibitors Merck Serono S.A. 10/26/152D 3D TSV
US9006244 14 Liver X receptor modulators Vitae Pharmaceuticals, Inc. 10/26/152D 3D TSV
US9006283 6 Methods of modifying amyloid β oligomers using non-peptidic compounds Acumen Pharmaceuticals, Inc. 10/26/152D 3D TSV
US9006268 10 Prolylcarboxypeptidase inhibitors Merck Sharp & Dohme Corp. 10/26/152D 3D TSV
US9006232 98 Pyrimidone derivatives Mitsubishi Tanabe Pharma Corporation 10/26/152D 3D TSV
US9006282 20 Rosuvastatin and atorvastatin derivatives Redx Pharma Limited 10/26/152D 3D TSV
US9006249 13 Substituted aminobutyric derivatives as neprilysin inhibitors Novartis AG 10/26/152D 3D TSV
US9006242 15 Substituted benzene compounds Epizyme, Inc. 10/26/152D 3D TSV
US9006246 15 Tetrahydrocarboline derivative Ono Pharmaceutical Co., Ltd. 10/26/152D 3D TSV
US9000182 41 2H-imidazol-4-amine compounds and their use as BACE inhibitors AstraZeneca AB 10/19/152D 3D TSV
US9000185 18 Cycloalkyl ether compounds and their use as BACE inhibitors AstraZeneca AB 10/19/152D 3D TSV
US9000183 21 Cyclohexane-1,2′-indene-1′,2″-imidazol compounds and their use as BACE inhibitors Astrazeneca AB 10/19/152D 3D TSV
US9000184 31 Cyclohexane-1,2′-naphthalene-1′,2″-imidazol compounds and their use as BACE inhibitors AstraZeneca AB 10/19/152D 3D TSV
US8999957 459 Heterocyclic compounds as ERK inhibitors Merck Sharp & Dohme Corp. 10/19/152D 3D TSV
US9000153 43 Imidazo[4,5-c]quinolines as DNA-PK inhibitors Merck Patent GmbH 10/19/152D 3D TSV
US9000043 4 Phenoxyethoxy compounds Eli Lilly and Company 10/19/152D 3D TSV
US9000029 118 Proline sulfonamide derivatives as orexin receptor antagonists Actelion Pharmaceuticals Ltd. 10/19/152D 3D TSV
US9000044 67 Substituted naphthylacetic acids Hoffmann-La Roche Inc. 10/19/152D 3D TSV
US9006187 34 Thiophene derivative as SGLT2 inhibitor and pharmaceutical composition comprising same Green Cross Corporation 10/19/152D 3D TSV
US8999981 252 3-amido-pyrrolo[3,4-C]pyrazole-5(1H, 4H,6H) carbaldehyde derivatives Pfizer Inc.; Pfizer Products Inc. 10/12/152D 3D TSV
US9012443 827 Bicyclic aryl and heteroaryl sodium channel inhibitors Amgen Inc. 10/12/152D 3D TSV
US9000008 5 Amides of acetic and propionic acids Bayer Intellectual Property GmbH 10/05/152D 3D TSV
US9000015 42 Compounds for the treatment of addiction Gilead Sciences, Inc. 10/05/152D 3D TSV
US8999994 36 Derivatives of propargylamine having neuroprotective capacity for the treatment of Alzheimer's and Parkinson's diseases Consejo Superior de Investigaciones Cientificas; Universitat Autonoma de Barcelona; Universidad de Barcelona 10/05/152D 3D TSV
US8999980 19 Oxazine derivatives Shionogi & Co., Ltd. 10/05/152D 3D TSV
US8999982 16 Pharmaceutically active compounds as Axl inhibitors Lead Discovery Center GmbH; Max-Planck-Gesellschaft zur Förderung der Wissenschaften E.V. 10/05/152D 3D TSV
US8993808 181 Phenylcyclopropylamine derivatives and their medical use Oryzon Genomics, S.A. 10/05/152D 3D TSV
US8999998 95 Pyrazolopyrimidine JAK inhibitor compounds and methods Genentech, Inc. 10/05/152D 3D TSV
US8999975 140 Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C Boehringer Ingelheim International GmbH 10/05/152D 3D TSV
US8999955 14 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological Centre National de la Recherche Scientifique 10/05/152D 3D TSV
US8993616 113 (aza)indole derivative and use thereof for medical purposes Kissei Pharmaceutical Co., Ltd. 09/28/152D 3D TSV
US8993596 3 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics Galderma Research & Development 09/28/152D 3D TSV
US8993631 43 Method of treating contrast-induced nephropathy Novartis AG 09/28/152D 3D TSV
US8993612 10 Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer Rhizen Pharmaceuticals SA 09/28/152D 3D TSV
US8993568 6 Morpholinyl derivatives useful as MOGAT-2 inhibitors Eli Lilly and Company 09/28/152D 3D TSV
US8993586 248 N1/N2-lactam acetyl-CoA carboxylase inhibitors Pfizer Inc. 09/28/152D 3D TSV
US8993756 226 Pyrrolopyrimidines as janus kinase inhibitors Merck Sharp & Dohme Corp. 09/28/152D 3D TSV
US8993614 52 Substituted pyrrolidine-2-carboxamides F. Hoffmann-La Roche AG 09/28/152D 3D TSV
US8993765 26 Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof Albany Molecular Research, Inc. 09/28/152D 3D TSV
US8993575 12 [1,3,4] oxadiazole derivative and application thereof Huazhong University of Science & Technology; NHWA Pharma Corporation 09/28/152D 3D TSV
US8993565 161 (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors Sanofi 09/03/152D 3D TSV
US8993552 72 Compositions and methods for treatment of leukemia The Regents of The University of Michigan; University of Virginia Patent Foundation 09/03/152D 3D TSV
US8987474 133 Inhibition of Shp2/PTPN11 protein tyrosine phosphatase by NSC-87877, NSC-117199 and their analogs University of South Florida; H. Lee Moffitt Cancer Center and Research Institute, Inc. 09/03/152D 3D TSV
US8993557 10 Pyridinedione carboxamide inhibitors of endothelial lipase Bristol-Myers Squibb Company 09/03/152D 3D TSV
US8993556 18 Resorcinol derivatives as HSP90 inhibitors Nerviano Medical Sciences S.R.L. 09/03/152D 3D TSV
US8987473 72 Ring-fused compound Sato Pharmaceutical Co., Ltd. 09/03/152D 3D TSV
US8987457 595 Ring-substituted N-pyridinyl amides as kinase inhibitors Novartis AG 09/03/152D 3D TSV
US8987319 37 Selective androgen receptor modulators Radius Health, Inc. 09/03/152D 3D TSV
US8987335 35 Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors University of Utah Research Foundation 09/03/152D 3D TSV
US8987445 181 Sulfonamide compounds having TRPM8 antagonistic activity Mitsubishi Tanabe Pharma Corporation 09/03/152D 3D TSV
US8987314 725 Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase Bristol-Myers Squibb Company 08/25/152D 3D TSV
US8987272 3 Compounds and method for treatment of HIV Critical Outcome Technologies Inc. 08/25/152D 3D TSV
US8987257 68 Heterocyclic derivatives Novartis AG 08/25/152D 3D TSV
US8987313 34 Inhibitors of cytochrome P450 Gilead Sciences, Inc. 08/25/152D 3D TSV
US8987315 20 Metalloenzyme inhibitor compounds Innocrin Pharmaceuticals, Inc. 08/25/152D 3D TSV
US8981106 177 Pyrimidinecarboxamides as CXCR2 modulators Syntrix Biosystems, Inc. 08/25/152D 3D TSV
US8987268 121 Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Bristol-Myers Squibb Company 08/25/152D 3D TSV
US8987287 25 Spirocyclic morphinans and their use Purdue Pharma L.P. 08/25/152D 3D TSV
US8987273 75 Substituted imidazo[1,2-B]pyridazines Bayer Intellectual Property GmbH 08/25/152D 3D TSV
US8987286 45 Substituted pyrimido[1,2-b]indazoles and their use as modulators of the Pi3K/Akt pathway Bayer Intellectual Property GmbH 08/25/152D 3D TSV
US8987239 20 19-nor-steroid derivatives with a 15α,16α-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives Bayer Intellectual Property GbmH 08/19/152D 3D TSV
US8980938 7 CXCR2 inhibitors Sanofi 08/19/152D 3D TSV
US8980932 40 Cancer targeting using carbonic anhydrase isoform IX inhibitors Stichting Maastricht Radiation Oncology “Maastro-Clinic”; Université Montpellier 2 Sciences et Techniques 08/19/152D 3D TSV
US8981112 25 Inhibitors of β-secretase Vitae Pharmaceuticals, Inc.; Boehringer-Ingelheim International GmbH 08/19/152D 3D TSV
US8987247 3 Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders Janssen Pharmaceutica NV 08/19/152D 3D TSV
US8987242 15 Morpholinone compounds as factor IXA inhibitors Merck Sharp & Dohme Corp.; Mochida Pharmaceuticals Co., Ltd. 08/19/152D 3D TSV
US8987249 358 Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C Boehringer Ingelheim International GmbH 08/19/152D 3D TSV
US8980954 13 Substituted cis- and trans-stilbenes as therapeutic agents STC.UNM 08/19/152D 3D TSV
US8987248 26 Substituted piperidines as Par-1 antagonists Bayer Intellectual Property GmbH 08/19/152D 3D TSV
US8987254 8 Tetrahydropyrrolothiazine compounds Eli Lilly and Company 08/19/152D 3D TSV
US8980887 7 2-aryl imidazo[1,2-a]pyridine-3-acetamide derivatives, preparation methods and uses thereof Institute of Pharmacology; Toxicology Academy of Military Medical Sciences P.L.A., China 08/10/152D 3D TSV
US8980901 5 5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta Icos Corporation 08/10/152D 3D TSV
US8980829 56 Aryl glycoside compound, preparation method and use thereof Shanghai Yingli Science and Technology Co., Ltd; Shanghai Chempartner Co., Ltd 08/10/152D 3D TSV
US8980905 10 Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors Leo Pharma A/S 08/10/152D 3D TSV
US8975415 367 Chromane compounds CoMentis, Inc. 08/10/152D 3D TSV
US8980916 3 Factor IXa inhibitors Merck Sharp & Dohme Corp.; Mochida Pharmaceutical Co., Ltd. 08/10/152D 3D TSV
US8980904 18 Heterocyclic substituted pyrimidine compound Xuanzhu Pharma Co., Ltd. 08/10/152D 3D TSV
US8975409 18 Phenyl derivative ONO Pharmaceutical Co., Ltd. 08/10/152D 3D TSV
US8975417 716 Pyrazolopyrrolidine derivatives and their use in the treatment of disease Novartis AG 08/10/152D 3D TSV
US8980906 50 Pyridonemorphinan analogs and biological activity on opioid receptors Purdue Pharma L.P. 08/10/152D 3D TSV
US8980929 14 Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes Merck Sharp & Dohme Corp. 08/10/152D 3D TSV
US8975250 13 5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases SANOFI 08/03/152D 3D TSV
US8975261 14 Aryloxmethyl cyclopropane derivatives as PDE10 inhibitors Merck Sharp & Dohme Corp. 08/03/152D 3D TSV
US8975249 94 Heterocyclic compounds and uses thereof Celgene Avilomics Research, Inc. 08/03/152D 3D TSV
US8975276 8 Inhibitors of PDE10 Bristol-Myers Squibb Company 08/03/152D 3D TSV
US8962860 19 Inhibitors of glutaminyl cyclase Probiodrug AG 08/03/152D 3D TSV
US8975247 27 Methods and compositions of treating a flaviviridae family viral infection The Board of Trustees of the Leland Stanford Junion University 08/03/152D 3D TSV
US8975252 2 Morpholine derivative Shanghai Pharmaceuticals Holding Co., Ltd.; Mitsubishi Tanabe Pharma Corporation 08/03/152D 3D TSV
US8975260 12 Pyridazinones, method of making, and method of use thereof Genetech, Inc; Gilead Connecticut, Inc. 08/03/152D 3D TSV
US8975265 371 Substituted imidazo[1,2-a]pyrimidines and —pyridines Bayer Intellectual Property GmbH 08/03/152D 3D TSV
US8975282 8 Substituted pyrazolone compounds and methods of use Sunshine Lake Pharma Co., Ltd.; Calitor Sciences, LLC 08/03/152D 3D TSV
US8975267 51 Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors Nerviano Medical Sciences S.r.l. 08/03/152D 3D TSV
US8962637 76 Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors Debiopharm S.A.; Aurigene Discovery Technologies Ltd. 07/22/152D 3D TSV
US8962651 8 Compounds for the treatment of hepatitis C Bristol-Myers Squibb Company 07/22/152D 3D TSV
US8962674 93 Curcumin derivative Tokyo Institute of Technology; Kyoto University 07/22/152D 3D TSV
US8962837 24 Nitrogen heterocycle derivatives, preparation thereof and application thereof in human therapeutics Pierre Fabre Medicament 07/22/152D 3D TSV
US8962646 38 Peripherally acting opioid compounds Alkermes, Inc. 07/22/152D 3D TSV
US8962659 4 Phenoxyethyl piperidine compounds Eli Lilly and Company 07/22/152D 3D TSV
US8962641 490 Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereof Boehringer Ingelheim International GmbH 07/22/152D 3D TSV
US8962630 205 Pyrrolopyrimidine compounds and their uses Novartis AG 07/22/152D 3D TSV
US8962664 3 Selective glycosidase inhibitors and uses thereof Simon Fraser University 07/22/152D 3D TSV
US8962859 12 Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use Amgen Inc. 07/22/152D 3D TSV
US8962648 231 Tricyclic compounds and PBK inhibitors containing the same OncoTherapy Science, Inc. 07/22/152D 3D TSV
US8957084 9 7,8-cyclicmorphinan analogs Purdue Pharma L.P. 07/15/152D 3D TSV
US8957219 12 Acetic acid amide derivative having inhibitory activity on endothelial lipase Shionogi & Co., Ltd. 07/15/152D 3D TSV
US8957103 18 Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment Johannes Gutenberg—Universitat Mainz 07/15/152D 3D TSV
US8962608 1192 Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors Merck Sharp & Dohme Corp. 07/15/152D 3D TSV
US8962616 41 Heterocyclic substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Pfizer Inc. 07/15/152D 3D TSV
US8957093 262 N-biphenylmethylindole modulators of PPARG The Scripps Research Institute 07/15/152D 3D TSV
US8962609 129 Pyrimidine compounds as inhibitors of protein kinases IKK epsilon and/or TBK-1, processes for their preparation, and pharmaceutical compositions containing them Domainex Limited 07/15/152D 3D TSV
US8962611 356 Substituted imidazopyridines as HDM2 inhibitors Merck Sharp & Dohme Corp. 07/15/152D 3D TSV
US8962619 36 Substituted imidazopyridinyl-aminopyridine compounds ArQule, Inc. 07/15/152D 3D TSV
US8962612 20 Tetrahydroisoquinoline derivative Astellas Pharma Inc. 07/15/152D 3D TSV
US8957075 28 O-GlcNAc transferase inhibitors and uses thereof President and Fellows of Harvard College 07/10/152D 3D TSV
US8957077 14 Pyrazolopyrimidine PDE 10 inhibitors Merck Sharp & Dohme Corp. 07/10/152D 3D TSV
US8957074 298 Pyrrolopyrimidine compounds as inhibitors of CDK4/6 Novartis AG 07/10/152D 3D TSV
US8957083 31 Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use Amgen Inc. 07/10/152D 3D TSV
US8957068 870 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH Novartis AG 07/09/152D 3D TSV
US8957064 185 Fused pyrimidines Bayer Intellectual Property GmbH 07/09/152D 3D TSV
US8957059 66 Modulators of serotonin receptors Janssen Pharmaceutica NV 07/09/152D 3D TSV
US8957073 378 Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors Amgen Inc. 07/09/152D 3D TSV
US8957057 4 Use of azaphilone compounds for the modulation of the activity of a nuclear hormone receptor Food Industry Research and Development Institute 07/09/152D 3D TSV
US8952177 191 1,2,6-substituted benzimidazoles as FLAP modulators Janssen Pharmaceutica NV 06/29/152D 3D TSV
US8952157 407 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases AbbVie Inc.; The Walter and Eliza Hall Institute of Medical Research 06/29/152D 3D TSV
US8952036 5 Benzoic acid derivative MDM2 inhibitor for the treatment of cancer Amgen Inc. 06/29/152D 3D TSV
US8952037 98 Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors Amgen Inc. 06/29/152D 3D TSV
US8956589 22 Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases Shiga University of Medical Science 06/29/152D 3D TSV
US8952027 12 Inhibitors of syk and JAK protein kinases Portola Pharmaceuticals, Inc. 06/29/152D 3D TSV
US8952025 3 Multifunctional radical quenchers and their uses Arizona Board of Regents, A Body Corporate of the State of Arizona Acting for and on Behalf of Arizona State University 06/29/152D 3D TSV
US8952169 708 N-substituted benzamides and methods of use thereof Xenon Pharmaceuticals Inc.; Genentech, Inc. 06/29/152D 3D TSV
US8952150 30 Prostaglandin transporter inhibitors and uses thereof Albert Einstein College of Medicine of Yeshiva University 06/29/152D 3D TSV
US8952128 168 Somatostatin-dopamine chimeric analogs Ipsen Pharma S.A.S. 06/29/152D 3D TSV
US8969583 55 3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors Allergan, Inc. 06/22/152D 3D TSV
US8952002 3 Aminoheteroaryl compounds and preparation method and use thereof Shanghai Allist Pharmaceuticals, Inc. 06/22/152D 3D TSV
US8969358 54 Buprenorphine analogs Purdue Pharma L.P. 06/22/152D 3D TSV
US8952008 50 Chemical compounds Pfizer Limited 06/22/152D 3D TSV
US8969348 10 Chymase inhibitors Boehringer Ingelheim International GmbH 06/22/152D 3D TSV
US8969336 95 Diamino heterocyclic carboxamide compound Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd. 06/22/152D 3D TSV
US8969578 13 Inhibitors of STAT3 University of Central Florida Research Foundation, Inc. 06/22/152D 3D TSV